| Prescription ID | TCMF3427 |
| Pinyin Name | Fu Shen Ning Pian |
| Chinese Name | å¤è‚¾å®ç‰‡ |
| English Name | Fu Shen Ning Tablets |
| Function Description | çƒæ·‹ |
| Indications | Heat stranguria disorder, Acute prostatitis, Chronic prostatitis, Salmonella pyelonephritis, Chronic pyelonephritis, Cystitis, Urethritis |
| Disease ICD-11 Category |
SA91 [Heat stranguria disorder (TM1), çƒæ·‹ (TM1)
]; GA91.Y [Other specified inflammatory and other diseases of prostate, 其他特指的å‰åˆ—腺炎性疾病 ]; GA91.0 [Chronic prostatitis, 慢性å‰åˆ—腺炎 ]; GC2Z [Diseases of the urinary system, unspecified, 泌尿系统疾病,未特指的 ]; GB55.Z [Chronic tubulo-interstitial nephritis, unspecified, 慢性肾å°ç®¡-间质肾炎,未特指的 ]; GC00 [Cystitis, 膀胱炎 ]; GC02.Y [Other specified urethritis and urethral syndrome, 其他特指的尿é“炎和尿é“综åˆå¾ ]; |
| Human Tissues Associated with Indication | Bladder |
| Reference | CFDA |
| Reference Book/link | http://samr.cfda.gov.cn/WS01/CL0001/ |
| Component ID | Latin Name | Chinese Name | Component Quantity | Barcode |
|---|---|---|---|---|
| TCMH241 | Plantago asiatica | 车å‰å | TCMH241 | ITSAB3641-14 |
| TCMH718 | Aristolochia manshuriensis | 关木通 | TCMH718 | GBVE2055-11 |
| TCMH177 | Polygonum aviculare | è¹è“„ | TCMH177 | ITSAG3700-14 |
| TCMH363 | Rheum officinale | 大黄 | TCMH363 | ITSAJ4685-14 |
| TCMH949 | Phellodendron amurense | é»„æŸ | TCMH949 | ITSAM1586-14 |
| TCMH1588 | Achyranthes bidentata | ç‰›è† | TCMH1588 | ITSAJ4612-14 |
| TCMH727 | Aristolochia fangchi | 广防己 | TCMH727 | |
| TCMH2641 | Gardenia jasminoides | æ €å | TCMH2641 | ITSAJ4473-14 |
| TCMH2624 | Anemarrhena asphodeloides | çŸ¥æ¯ | TCMH2624 | GBVA3255-11, GBVU1201-13 |
| TCMH1706 | Dianthus superbus | 瞿麦 | TCMH1706 | ITSAJ4556-14 |
| TCMH1753 | Boswellia carterii | 乳香 | TCMH1753 |
| Target ID | Gene Symbol | Target Name | Target Class | Uniprot ID |
|---|---|---|---|---|
| TCMT100 | TTR | Transthyretin | Unclassified | P02766 |
| TCMT101 | PTPN1 | Protein-tyrosine phosphatase 1B | Hydrolase | P18031 |
| TCMT102 | ACP1 | Low molecular weight phosphotyrosine protein phosphatase | Hydrolase | P24666 |
| TCMT103 | PTPRF | Receptor-type tyrosine-protein phosphatase F (LAR) | Hydrolase | P10586 |
| TCMT107 | GRIK2 | Glutamate receptor ionotropic kainate 2 | Ion channel | Q13002 |
| TCMT109 | GRIA2 | Glutamate receptor ionotropic, AMPA 2 | Ion channel | P42262 |
| TCMT110 | GRIA4 | Glutamate receptor ionotropic, AMPA 4 | Ion channel | P48058 |
| TCMT111 | GRIK5 | Glutamate receptor ionotropic kainate 5 | Ion channel | Q16478 |
| TCMT112 | ADORA3 | Adenosine A3 receptor | GPCR | P0DMS8 |
| TCMT114 | CNR2 | Cannabinoid CB2 receptor | GPCR | P34972 |
| TCMT115 | CNR1 | Cannabinoid CB1 receptor | GPCR | P21554 |
| TCMT126 | TERT | Telomerase reverse transcriptase | Transferase | O14746 |
| TCMT127 | PARP1 | Poly [ADP-ribose] polymerase-1 | Transferase | P09874 |
| TCMT13 | APEX1 | DNA-(apurinic or apyrimidinic site) lyase | Lyase | P27695 |
| TCMT130 | ALOX5 | Arachidonate 5-lipoxygenase | Oxidoreductase | P09917 |
| TCMT131 | ACHE | Acetylcholinesterase | Hydrolase | P22303 |
| TCMT133 | CA1 | Carbonic anhydrase I | Lyase | P00915 |
| TCMT134 | CA2 | Carbonic anhydrase II | Lyase | P00918 |
| TCMT135 | CA14 | Carbonic anhydrase XIV | Lyase | Q9ULX7 |
| TCMT136 | CA12 | Carbonic anhydrase XII | Lyase | O43570 |
| TCMT137 | CA9 | Carbonic anhydrase IX | Lyase | Q16790 |
| TCMT138 | CA7 | Carbonic anhydrase VII | Lyase | P43166 |
| TCMT142 | CA4 | Carbonic anhydrase IV | Lyase | P22748 |
| TCMT150 | RORC | Nuclear receptor ROR-gamma | Nuclear receptor | P51449 |
| TCMT151 | PRKCA | Protein kinase C alpha | Kinase | P17252 |
| TCMT156 | CYP19A1 | Cytochrome P450 19A1 | Oxidoreductase | P11511 |
| TCMT159 | TYR | Tyrosinase | Oxidoreductase | P14679 |
| TCMT160 | HTR7 | Serotonin 7 (5-HT7) receptor | GPCR | P34969 |
| TCMT161 | HCAR2 | Hydroxycarboxylic acid receptor 2 | GPCR | Q8TDS4 |
| TCMT162 | UGT1A1 | UDP-glucuronosyltransferase 1-1 | Transferase | P22309 |
| TCMT164 | PTGS1 | Cyclooxygenase-1 | Oxidoreductase | P23219 |
| TCMT174 | HSD11B1 | 11-beta-hydroxysteroid dehydrogenase 1 | Oxidoreductase | P28845 |
| TCMT186 | MAOB | Monoamine oxidase B | Oxidoreductase | P27338 |
| TCMT187 | AR | Androgen Receptor | Nuclear receptor | P10275 |
| TCMT190 | PTPN2 | T-cell protein-tyrosine phosphatase | Hydrolase | P17706 |
| TCMT2 | MAPT | Microtubule-associated protein tau | Unclassified | P10636 |
| TCMT207 | BACE1 | Beta-secretase 1 | Protease | P56817 |
| TCMT209 | HSD11B2 | 11-beta-hydroxysteroid dehydrogenase 2 | Oxidoreductase | P80365 |
| TCMT212 | SRC | Tyrosine-protein kinase SRC | Kinase | P12931 |
| TCMT215 | CYP1A1 | Cytochrome P450 1A1 | Oxidoreductase | P04798 |
| TCMT217 | CYP2C8 | Cytochrome P450 2C8 | Oxidoreductase | P10632 |
| TCMT219 | CYP1A2 | Cytochrome P450 1A2 | Oxidoreductase | P05177 |
| TCMT22 | ALPI | Intestinal alkaline phosphatase | Hydrolase | P09923 |
| TCMT223 | AKR1B1 | Aldose reductase | Oxidoreductase | P15121 |
| TCMT23 | ALPL | Alkaline phosphatase, tissue-nonspecific isozyme | Hydrolase | P05186 |
| TCMT232 | ABCB1 | P-glycoprotein 1 | Transporter | P08183 |
| TCMT239 | PIM1 | Serine/threonine-protein kinase PIM1 | Kinase | P11309 |
| TCMT257 | CYP1B1 | Cytochrome P450 1B1 | Oxidoreductase | Q16678 |
| TCMT260 | FLT3 | Tyrosine-protein kinase receptor FLT3 | Kinase | P36888 |
| TCMT261 | DAPK1 | Death-associated protein kinase 1 | Kinase | P53355 |
| TCMT27 | DRD1 | Dopamine D1 receptor | GPCR | P21728 |
| TCMT280 | AKR1B10 | Aldo-keto reductase family 1 member B10 | Oxidoreductase | O60218 |
| TCMT295 | MMP1 | Matrix metalloproteinase-1 | Hydrolase | P03956 |
| TCMT297 | FABP4 | Fatty acid binding protein adipocyte | Unclassified | P15090 |
| TCMT3 | ALOX15 | Arachidonate 15-lipoxygenase | Oxidoreductase | P16050 |
| TCMT30 | PTGS2 | Cyclooxygenase-2 | Oxidoreductase | P35354 |
| TCMT304 | MMP14 | Matrix metalloproteinase 14 | Hydrolase | P50281 |
| TCMT306 | MMP2 | Matrix metalloproteinase-2 | Hydrolase | P08253 |
| TCMT313 | HTR2B | Serotonin 2b (5-HT2b) receptor | GPCR | P41595 |
| TCMT314 | HTR2C | Serotonin 2c (5-HT2c) receptor | GPCR | P28335 |
| TCMT315 | HTR6 | Serotonin 6 (5-HT6) receptor | GPCR | P50406 |
| TCMT318 | HKDC1 | Putative hexokinase HKDC1 | Transferase | Q2TB90 |
| TCMT321 | MMP9 | Matrix metalloproteinase 9 | Hydrolase | P14780 |
| TCMT322 | MMP13 | Matrix metalloproteinase 13 | Hydrolase | P45452 |
| TCMT329 | NQO2 | Quinone reductase 2 | Oxidoreductase | P16083 |
| TCMT33 | CYP3A4 | Cytochrome P450 3A4 | Oxidoreductase | P08684 |
| TCMT36 | HTR1A | Serotonin 1a (5-HT1a) receptor | GPCR | P08908 |
| TCMT369 | IGF1R | Insulin-like growth factor I receptor | Kinase | P08069 |
| TCMT37 | HTR2A | Serotonin 2a (5-HT2a) receptor | GPCR | P28223 |
| TCMT370 | KDR | Vascular endothelial growth factor receptor 2 | Kinase | P35968 |
| TCMT374 | AURKB | Serine/threonine-protein kinase Aurora-B | Kinase | Q96GD4 |
| TCMT38 | DRD2 | Dopamine D2 receptor | GPCR | P14416 |
| TCMT384 | GRK6 | G protein-coupled receptor kinase 6 | Kinase | P43250 |
| TCMT388 | AXL | Tyrosine-protein kinase receptor UFO | Kinase | P30530 |
| TCMT39 | PDE5A | Phosphodiesterase 5A | Hydrolase | O76074 |
| TCMT401 | MET | Hepatocyte growth factor receptor | Kinase | P08581 |
| TCMT422 | CAMK2B | CaM kinase II beta | Kinase | Q13554 |
| TCMT44 | GLO1 | Glyoxalase I | Lyase | Q04760 |
| TCMT445 | NEK2 | Serine/threonine-protein kinase NEK2 | Kinase | P51955 |
| TCMT45 | APP | Beta amyloid A4 protein | Unclassified | P05067 |
| TCMT46 | F3 | Coagulation factor III | Unclassified | P13726 |
| TCMT462 | NEK6 | Serine/threonine-protein kinase NEK6 | Kinase | Q9HC98 |
| TCMT47 | BCL2 | Apoptosis regulator Bcl-2 | Ion channel | P10415 |
| TCMT479 | AKT1 | Serine/threonine-protein kinase AKT | Kinase | P31749 |
| TCMT484 | PLK1 | Serine/threonine-protein kinase PLK1 | Kinase | P53350 |
| TCMT506 | PTK2B | Protein tyrosine kinase 2 beta | Kinase | Q14289 |
| TCMT508 | SYK | Tyrosine-protein kinase SYK | Kinase | P43405 |
| TCMT510 | KIT | Stem cell growth factor receptor | Kinase | P10721 |
| TCMT558 | TOP2A | DNA topoisomerase II alpha | Isomerase | P11388 |
| TCMT563 | CDC25B | Dual specificity phosphatase Cdc25B | Hydrolase | P30305 |
| TCMT567 | DNMT1 | DNA (cytosine-5)-methyltransferase 1 | Transferase | P26358 |
| TCMT592 | XDH | Xanthine dehydrogenase | Oxidoreductase | P47989 |
| TCMT599 | UBE2N | Ubiquitin-conjugating enzyme E2 N | Transferase | P61088 |
| TCMT613 | NR3C1 | Glucocorticoid receptor | Nuclear receptor | P04150 |
| TCMT63 | PPARA | Peroxisome proliferator-activated receptor alpha | Nuclear receptor | Q07869 |
| TCMT637 | SIRT3 | NAD-dependent deacetylase sirtuin 3 | Hydrolase | Q9NTG7 |
| TCMT638 | SIRT2 | NAD-dependent deacetylase sirtuin 2 | Hydrolase | Q8IXJ6 |
| TCMT645 | HTR1E | Serotonin 1e (5-HT1e) receptor | GPCR | P28566 |
| TCMT646 | HTR5A | Serotonin 5a (5-HT5a) receptor | GPCR | P47898 |
| TCMT65 | HSD17B1 | Estradiol 17-beta-dehydrogenase 1 | Oxidoreductase | P14061 |
| TCMT653 | GRM1 | Metabotropic glutamate receptor 1 | GPCR | Q13255 |
| TCMT654 | GRM5 | Metabotropic glutamate receptor 5 | GPCR | P41594 |
| TCMT655 | GRM2 | Metabotropic glutamate receptor 2 | GPCR | Q14416 |
| TCMT656 | GRM3 | Metabotropic glutamate receptor 3 | GPCR | Q14832 |
| TCMT657 | GRM4 | Metabotropic glutamate receptor 4 | GPCR | Q14833 |
| TCMT66 | HSD17B2 | Estradiol 17-beta-dehydrogenase 2 | Oxidoreductase | P37059 |
| TCMT660 | GRM8 | Metabotropic glutamate receptor 8 | GPCR | O00222 |
| TCMT664 | SLC1A1 | Excitatory amino acid transporter 3 | Transporter | P43005 |
| TCMT729 | PIK3CA | PI3-kinase p110-alpha subunit | Transferase | P42336 |
| TCMT730 | PIK3CB | PI3-kinase p110-beta subunit | Transferase | P42338 |
| TCMT734 | MMP12 | Matrix metalloproteinase 12 | Hydrolase | P39900 |
| TCMT737 | APOBEC3G | DNA dC->dU-editing enzyme APOBEC-3G | Unclassified | Q9HC16 |
| TCMT740 | PIK3CG | PI3-kinase p110-gamma subunit | Transferase | P48736 |
| TCMT751 | DYRK1A | Dual-specificity tyrosine-phosphorylation regulated kinase 1A | Kinase | Q13627 |
| TCMT752 | CSNK2A1 | Casein kinase II alpha | Kinase | P68400 |
| TCMT783 | NR3C2 | Mineralocorticoid receptor | Nuclear receptor | P08235 |
| TCMT784 | AVPR2 | Vasopressin V2 receptor | GPCR | P30518 |
| TCMT785 | CXCR1 | Interleukin-8 receptor A | GPCR | P25024 |
| TCMT786 | CCR4 | C-C chemokine receptor type 4 | GPCR | P51679 |
| TCMT791 | PKN1 | Protein kinase N1 | Kinase | Q16512 |
| TCMT793 | PYGL | Liver glycogen phosphorylase | Transferase | P06737 |
| TCMT8 | KDM4E | Lysine-specific demethylase 4D-like | Oxidoreductase | B2RXH2 |
| TCMT808 | FABP5 | Fatty acid binding protein epidermal | Unclassified | Q01469 |
| TCMT809 | FABP2 | Fatty acid binding protein intestinal | Unclassified | P12104 |
| TCMT810 | TLR2 | Toll-like receptor 2 | Unclassified | O60603 |
| TCMT815 | HTR1D | Serotonin 1d (5-HT1d) receptor | GPCR | P28221 |
| TCMT816 | HTR1B | Serotonin 1b (5-HT1b) receptor | GPCR | P28222 |
| TCMT817 | HTR4 | Serotonin 4 (5-HT4) receptor | GPCR | Q13639 |
| TCMT82 | ESR1 | Estrogen receptor alpha | Nuclear receptor | P03372 |
| TCMT822 | FUT7 | Alpha-(1,3)-fucosyltransferase 7 | Transferase | Q11130 |
| TCMT83 | CD38 | Lymphocyte differentiation antigen CD38 | Unclassified | P28907 |
| TCMT904 | PGR | Progesterone receptor | Nuclear receptor | P06401 |
| Target ID | Target Name |
|---|---|
| TCMT1170 | Enterobacter cloacae |
| TCMT1175 | Human immunodeficiency virus |
| TCMT1176 | Streptococcus pneumoniae |
| TCMT1178 | Actinomyces viscosus |
| TCMT1182 | Streptococcus sanguinis |
| TCMT1183 | Candida albicans SC5314 |
| TCMT1189 | Pseudomonas fluorescens |
| TCMT1190 | Plasmodium falciparum (isolate FcB1 / Columbia) |
| TCMT1198 | Serratia marcescens |
| TCMT1201 | Staphylococcus epidermidis ATCC 12228 |
| TCMT1208 | Escherichia coli K12 |
| TCMT1209 | Staphylococcus haemolyticus |
| TCMT1212 | Verticillium dahliae |
| TCMT1213 | Neisseria gonorrhoeae |
| TCMT1215 | Pseudomonas aeruginosa PAO1 |
| TCMT1218 | Staphylococcus aureus |
| TCMT1219 | Enterococcus |
| TCMT1222 | Plasmodium falciparum D6 |
| TCMT1223 | Staphylococcus epidermidis |
| TCMT1226 | Klebsiella pneumoniae |
| TCMT1229 | Enterococcus faecalis |
| TCMT1230 | Human herpesvirus 5 |
| TCMT1231 | Human herpesvirus 1 strain KOS |
| TCMT1232 | Pseudomonas aeruginosa |
| TCMT1236 | Mycobacterium bovis |
| TCMT1243 | Aspergillus flavus |
| TCMT1246 | Escherichia coli |
| TCMT1247 | Human herpesvirus 1 |
| TCMT1248 | Hepatitis C virus |
| TCMT1249 | Dengue virus 2 |
| TCMT1251 | Candida albicans |
| TCMT1253 | Penicillium chrysogenum |
| TCMT1255 | Human immunodeficiency virus 1 |
| TCMT1286 | Bacillus cereus |
| TCMT1289 | Shigella dysenteriae |
| TCMT1294 | Human parainfluenza virus 3 |
| TCMT1296 | Influenza A virus H3N2 |
| TCMT1305 | Salmonella enteritidis |
| TCMT1318 | Human T-lymphotropic virus 1 |
| TCMT1346 | Helicobacter pylori |
| TCMT1349 | Helicobacter pylori SS1 |
| TCMT1353 | Plasmodium yoelii |
| TCMT1361 | Neisseria meningitidis |
| TCMT1382 | Plasmodium falciparum (isolate K1 / Thailand) |
| TCMT1385 | Candida shehatae |
| TCMT1390 | Human herpesvirus 2 strain G |
| TCMT1412 | Salmonella typhimurium |
| TCMT1438 | Plasmodium falciparum |
| TCMT1439 | Mycobacterium smegmatis |
| TCMT1442 | Leishmania donovani |
| TCMT1443 | Leishmania amazonensis |
| TCMT1447 | Respiratory syncytial virus |
| TCMT1448 | Enterobacter aerogenes |
| TCMT1449 | Influenza A virus |
| TCMT1450 | Plasmodium falciparum 3D7 |
| TCMT1454 | Bacillus subtilis |
| TCMT1455 | Mycobacterium tuberculosis H37Rv |
| TCMT1458 | Filobasidiella neoformans |
| TCMT1460 | Mycobacterium intracellulare |
| TCMT1462 | Streptococcus mutans |
| TCMT1463 | Mycobacterium tuberculosis |
| TCMT1464 | Hepatitis B virus |
| TCMT1465 | Entamoeba histolytica |
| GO Term | GO Name | Enriched Genes | Log10 Adjusted P-value |
|---|---|---|---|
| [BP] GO:0065008 | regulation of biological quality | ABCB1, ACHE, AKR1B1, ALOX15, APEX1, APP, AR, AURKB, AXL, BCL2, CA12, CA2, CA7, CNR1, CNR2, CYP19A1, CYP1A1, CYP1B1, CYP3A4, DRD1, DRD2, ESR1, F3, FABP4, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM5, HCAR2, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR2C, HTR4, HTR7, KDR, KIT, MAOB, MET, PIK3CA, PIK3CB, PPARA, PRKCA, PTGS1, PTGS2, SLC1A1, SRC, TERT, XDH | 16.1574 |
| [BP] GO:0007210 | None | HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7 | 15.8141 |
| [BP] GO:0098664 | None | HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7 | 15.8141 |
| [BP] GO:0042221 | response to chemical | ABCB1, AKR1B1, ALOX15, ALPL, APEX1, APP, AR, AXL, BCL2, CA2, CA9, CNR1, CNR2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DNMT1, DRD1, DRD2, ESR1, FABP4, FLT3, GRIK5, GRM5, HSD11B2, HSD17B2, HTR1B, HTR1D, HTR2A, HTR2B, HTR2C, HTR5A, IGF1R, KDR, KIT, MAOB, MMP2, MMP9, NR3C1, PIK3CA, PPARA, PRKCA, PTGS2, RORC, SRC, TERT, TYR | 15.0719 |
| [BP] GO:1901700 | response to oxygen-containing compound | AKR1B1, ALPL, APEX1, APP, AR, AXL, BCL2, CA9, CNR1, CNR2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DNMT1, DRD1, DRD2, ESR1, GRIK5, GRM5, HSD11B2, HSD17B2, HTR1B, HTR5A, IGF1R, MAOB, MMP2, MMP9, NR3C1, PIK3CA, PPARA, PTGS2, RORC, SRC, TYR | 13.9916 |
| [BP] GO:0010033 | response to organic substance | AKR1B1, ALOX15, ALPL, APEX1, APP, AR, AXL, BCL2, CA2, CA9, CNR1, CNR2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DNMT1, DRD1, DRD2, ESR1, FABP4, FLT3, GRIK5, GRM5, HSD11B2, HSD17B2, HTR1B, HTR5A, IGF1R, KDR, KIT, MAOB, MMP2, NR3C1, PIK3CA, PPARA, PRKCA, PTGS2, RORC, SRC, TYR | 12.9814 |
| [BP] GO:0007187 | None | CNR1, CNR2, DRD1, DRD2, GRM1, GRM3, GRM5, GRM8, HTR1A, HTR1B, HTR1D, HTR1E, HTR4, HTR5A, HTR6, HTR7 | 12.2657 |
| [BP] GO:0050804 | modulation of chemical synaptic transmission | ACHE, APP, BACE1, CA2, CA7, CNR1, CNR2, DRD1, DRD2, GRIK5, GRM1, GRM3, GRM5, GRM8, HTR1B, HTR2A, KIT, PTGS2 | 11.3036 |
| [BP] GO:0099177 | regulation of trans-synaptic signaling | ACHE, APP, BACE1, CA2, CA7, CNR1, CNR2, DRD1, DRD2, GRIK5, GRM1, GRM3, GRM5, GRM8, HTR1B, HTR2A, KIT, PTGS2 | 11.3036 |
| [BP] GO:0014070 | response to organic cyclic compound | ALPL, APEX1, APP, AR, BCL2, CA2, CA9, CNR1, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, ESR1, FLT3, HSD11B2, HTR1B, HTR5A, MAOB, NR3C1, PTGS2, RORC, SRC, TYR | 11.2987 |
| [BP] GO:0010647 | positive regulation of cell communication | AKR1B1, ALOX15, APP, AR, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, F3, FLT3, GRM1, HCAR2, HTR2A, HTR2B, HTR2C, HTR6, KDR, KIT, MET, MMP12, MMP9, PDE5A, PIK3CA, PIK3CB, PRKCA, PTGS2, PTPN1, SRC, TERT, XDH | 10.9434 |
| [BP] GO:0023056 | positive regulation of signaling | AKR1B1, ALOX15, APP, AR, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, F3, FLT3, GRM1, HCAR2, HTR2A, HTR2B, HTR2C, HTR6, KDR, KIT, MET, MMP12, MMP9, PDE5A, PIK3CA, PIK3CB, PRKCA, PTGS2, PTPN1, SRC, TERT, XDH | 10.9035 |
| [BP] GO:0010646 | regulation of cell communication | ACHE, AKR1B1, ALOX15, APP, AR, AURKB, AXL, BACE1, BCL2, CA2, CA7, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DYRK1A, ESR1, F3, FLT3, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, HTR1A, HTR1B, HTR2A, HTR2B, HTR2C, HTR6, IGF1R, KDR, KIT, MET, MMP12, MMP9, PDE5A, PIK3CA, PIK3CB, PRKCA, PTGS2, PTPN1, SRC, TERT, XDH | 10.8114 |
| [BP] GO:0023051 | regulation of signaling | ACHE, AKR1B1, ALOX15, APP, AR, AURKB, AXL, BACE1, BCL2, CA2, CA7, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DYRK1A, ESR1, F3, FLT3, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, HTR1A, HTR1B, HTR2A, HTR2B, HTR2C, HTR6, IGF1R, KDR, KIT, MET, MMP12, MMP9, PDE5A, PIK3CA, PIK3CB, PRKCA, PTGS2, PTPN1, SRC, TERT, XDH | 10.6159 |
| [BP] GO:0099536 | None | CNR1, DRD1, DRD2, GRIA2, GRIK5, GRM1, GRM3, GRM5, HTR1B, HTR1D, HTR1E, HTR2A, HTR2C, HTR4, HTR6, HTR7, SLC1A1 | 10.3199 |
| [BP] GO:0099537 | None | CNR1, DRD1, DRD2, GRIA2, GRIK5, GRM1, GRM3, GRM5, HTR1B, HTR1D, HTR1E, HTR2A, HTR2C, HTR4, HTR6, HTR7, SLC1A1 | 10.3199 |
| [BP] GO:0007193 | None | DRD2, GRM1, GRM3, GRM5, GRM8, HTR1A, HTR1B, HTR1D, HTR1E, HTR5A, HTR7 | 10.2755 |
| [BP] GO:0051966 | regulation of synaptic transmission, glutamatergic | CNR1, DRD1, DRD2, GRM1, GRM3, GRM5, GRM8, HTR1B, HTR2A, PTGS2 | 9.87021 |
| [BP] GO:0048522 | positive regulation of cellular process | ACHE, AKR1B1, ALOX15, APEX1, APP, AR, AURKB, AXL, BCL2, CA2, CA7, CDC25B, CNR1, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DNMT1, DRD1, DRD2, DYRK1A, ESR1, F3, FLT3, GRIK5, GRM1, GRM5, HCAR2, HTR1A, HTR1B, HTR2A, HTR2B, HTR2C, HTR6, IGF1R, KDR, KIT, MAOB, MET, MMP1, MMP12, MMP2, MMP9, NR3C1, PDE5A, PGR, PIK3CA, PIK3CB, PIM1, PPARA, PRKCA, PTGS2, PTPN1, RORC, SRC, TERT, TOP2A, XDH | 9.85997 |
| [BP] GO:0033993 | response to lipid | ALPL, AR, AXL, BCL2, CA2, CA9, CNR1, CNR2, CSNK2A1, CYP1A1, CYP1A2, ESR1, FLT3, HSD11B2, HSD17B2, HTR1B, HTR5A, MAOB, NR3C1, PTGS2, RORC, SRC, TYR | 9.64743 |
| [BP] GO:1902533 | positive regulation of intracellular signal transduction | AKR1B1, ALOX15, APP, AR, AXL, BCL2, CYP1B1, DRD2, F3, FLT3, GRM1, HTR2A, HTR2B, HTR2C, HTR6, KDR, KIT, MET, PDE5A, PIK3CA, PIK3CB, PRKCA, PTGS2, PTPN1, SRC, XDH | 9.49889 |
| [BP] GO:0007188 | None | CNR1, DRD1, DRD2, GRM1, GRM3, GRM5, GRM8, HTR1A, HTR1B, HTR1D, HTR1E, HTR5A, HTR7 | 9.48731 |
| [BP] GO:0009719 | response to endogenous stimulus | AKR1B1, ALPL, APEX1, APP, AR, BCL2, CA2, CA9, CSNK2A1, CYP1A2, DNMT1, DRD1, ESR1, FLT3, GRM5, HSD11B2, HTR1B, HTR5A, IGF1R, KIT, MAOB, MMP2, NR3C1, PPARA, PTGS2, SRC | 9.4484 |
| [BP] GO:0010035 | response to inorganic substance | AKR1B1, ALOX15, APEX1, APP, AXL, BCL2, CA2, CYP1A1, CYP1A2, CYP1B1, DRD2, FABP4, KDR, KIT, MAOB, MMP9, PTGS2, SRC, TERT | 9.43987 |
| [BP] GO:0007268 | None | DRD1, DRD2, GRIA2, GRIK5, GRM1, GRM3, GRM5, HTR1B, HTR1D, HTR1E, HTR2A, HTR2C, HTR4, HTR6, HTR7, SLC1A1 | 9.43899 |
| [BP] GO:0098916 | None | DRD1, DRD2, GRIA2, GRIK5, GRM1, GRM3, GRM5, HTR1B, HTR1D, HTR1E, HTR2A, HTR2C, HTR4, HTR6, HTR7, SLC1A1 | 9.43899 |
| [BP] GO:0048518 | positive regulation of biological process | ABCB1, ACHE, AKR1B1, ALOX15, APEX1, APP, AR, AURKB, AXL, BCL2, CA2, CA7, CDC25B, CNR1, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DNMT1, DRD1, DRD2, DYRK1A, ESR1, F3, FABP4, FLT3, GRIK5, GRM1, GRM5, HCAR2, HTR1A, HTR1B, HTR2A, HTR2B, HTR2C, HTR6, IGF1R, KDR, KIT, MAOB, MET, MMP1, MMP12, MMP2, MMP9, NR3C1, PDE5A, PGR, PIK3CA, PIK3CB, PIM1, PPARA, PRKCA, PTGS2, PTPN1, RORC, SLC1A1, SRC, TERT, TOP2A, XDH | 9.34267 |
| [BP] GO:0050896 | response to stimulus | ABCB1, ACHE, ADORA3, AKR1B1, ALOX15, ALPL, APEX1, APP, AR, AURKB, AXL, BCL2, CA2, CA9, CNR1, CNR2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DNMT1, DRD1, DRD2, ESR1, F3, FABP4, FLT3, GRIK5, GRM1, GRM5, HSD11B2, HSD17B2, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR2C, HTR5A, IGF1R, KDR, KIT, MAOB, MMP12, MMP2, MMP9, NR3C1, PIK3CA, PIK3CB, PPARA, PRKCA, PTGS1, PTGS2, PTPN1, RORC, SRC, TERT, TOP2A, TYR | 9.25004 |
| [BP] GO:0032501 | multicellular organismal process | AKR1B1, AKR1B10, ALOX15, ALOX5, ALPI, ALPL, APP, AR, AXL, BCL2, CNR1, CNR2, CYP19A1, CYP1A2, CYP1B1, DRD1, DRD2, ESR1, F3, FABP4, GRM1, GRM5, GRM8, HSD11B2, HSD17B2, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR2C, HTR7, IGF1R, KIT, MET, MMP1, MMP12, MMP2, MMP9, PDE5A, PIK3CA, PIM1, PPARA, PTGS2, RORC, SRC, TYR | 9.25004 |
| [BP] GO:0006629 | lipid metabolic process | ACHE, AKR1B1, AKR1B10, ALOX15, ALOX5, ALPI, APP, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD2, ESR1, FABP4, FUT7, HSD11B1, HSD11B2, HSD17B1, HSD17B2, KIT, MET, PIK3CA, PIK3CB, PPARA, PTGS1, PTGS2 | 9.12392 |
| [BP] GO:0043067 | regulation of programmed cell death | AKR1B1, APEX1, AR, AURKB, AXL, BCL2, CNR1, CSNK2A1, CYP1B1, ESR1, F3, FLT3, GLO1, GRIK5, HCAR2, HTR2B, IGF1R, KDR, KIT, MET, MMP9, PIK3CA, PIK3CB, PIM1, PRKCA, PTGS2, PTPN1, SRC, TERT, TOP2A, XDH | 9.00647 |
| [BP] GO:0042127 | regulation of cell proliferation | ADORA3, AKR1B1, APP, AR, BCL2, CDC25B, CSNK2A1, CYP1B1, DNMT1, DRD2, ESR1, F3, FLT3, HTR1A, HTR1B, HTR2A, HTR2B, IGF1R, KDR, KIT, MMP12, MMP2, MMP9, PDE5A, PGR, PIM1, PRKCA, PTGS1, PTGS2, SRC, TERT, XDH | 8.95311 |
| [BP] GO:0010941 | regulation of cell death | AKR1B1, APEX1, AR, AURKB, AXL, BCL2, CNR1, CSNK2A1, CYP1B1, ESR1, F3, FLT3, GLO1, GRIK5, HCAR2, HTR2B, IGF1R, KDR, KIT, MET, MMP9, PIK3CA, PIK3CB, PIM1, PPARA, PRKCA, PTGS2, PTPN1, SRC, TERT, TOP2A, XDH | 8.92565 |
| [BP] GO:0042493 | response to drug | ABCB1, AKR1B1, APEX1, AXL, BCL2, CA9, CNR1, CNR2, CYP1A1, CYP1B1, DRD1, DRD2, HSD11B2, HTR1B, HTR2A, HTR2B, HTR2C, KDR, MAOB, NR3C1, PTGS2, SRC | 8.68495 |
| [BP] GO:0032879 | regulation of localization | ABCB1, ACHE, ADORA3, ALOX15, APEX1, APP, AR, AXL, BCL2, CA2, CA7, CNR1, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, F3, GRIK5, GRM5, HCAR2, HTR1A, HTR1B, HTR2A, HTR2B, HTR2C, IGF1R, KDR, KIT, MAOB, MET, MMP12, MMP9, PIK3CB, PPARA, PRKCA, PTGS2, PTPN1, SRC, TERT | 8.66254 |
| [BP] GO:0007165 | signal transduction | ADORA3, AKR1B1, APP, AR, AXL, BCL2, CA1, CA2, CNR1, CNR2, CSNK2A1, CYP1B1, DNMT1, DRD1, DRD2, ESR1, F3, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IGF1R, KDR, KIT, MET, MMP2, MMP9, NR3C1, NR3C2, PDE5A, PGR, PIK3CA, PIK3CB, PIM1, PPARA, PRKCA, PTPN1, RORC, SRC | 8.61012 |
| [BP] GO:0070887 | cellular response to chemical stimulus | AKR1B1, ALOX15, ALPL, APEX1, APP, AR, AXL, BCL2, CYP1A1, CYP1A2, CYP1B1, DNMT1, DRD1, ESR1, FABP4, FLT3, GRIK5, GRM5, HTR1B, IGF1R, KDR, KIT, MMP2, MMP9, NR3C1, PIK3CA, PTGS2, RORC, SRC, TERT | 8.54985 |
| [BP] GO:0009967 | positive regulation of signal transduction | AKR1B1, ALOX15, APP, AR, AXL, BCL2, CSNK2A1, CYP1B1, DRD2, F3, FLT3, GRM1, HTR2A, HTR2B, HTR2C, HTR6, KDR, KIT, MET, MMP12, MMP9, PDE5A, PIK3CA, PIK3CB, PRKCA, PTGS2, PTPN1, SRC, TERT, XDH | 8.36073 |
| [BP] GO:0071310 | cellular response to organic substance | AKR1B1, ALOX15, ALPL, APEX1, APP, AR, AXL, BCL2, CYP1A1, CYP1B1, DNMT1, DRD1, ESR1, FABP4, FLT3, GRIK5, GRM5, HTR1B, IGF1R, KDR, KIT, MMP2, NR3C1, PIK3CA, PTGS2, RORC, SRC | 8.32368 |
| [BP] GO:0008284 | positive regulation of cell proliferation | AKR1B1, AR, BCL2, CDC25B, CSNK2A1, DRD2, ESR1, F3, FLT3, HTR1A, HTR1B, HTR2A, HTR2B, IGF1R, KDR, KIT, MMP12, MMP2, MMP9, PIM1, PRKCA, PTGS2, TERT | 8.02471 |
| [BP] GO:0007215 | None | APP, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8 | 7.9297 |
| [BP] GO:0010817 | regulation of hormone levels | ACHE, AKR1B1, CNR1, CYP19A1, CYP1A1, CYP1B1, CYP3A4, DRD2, ESR1, HCAR2, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HTR1A, HTR2A, HTR2C, PRKCA | 7.89232 |
| [BP] GO:0009725 | response to hormone | AKR1B1, ALPL, APEX1, AR, BCL2, CA2, CA9, CSNK2A1, CYP1A2, ESR1, FLT3, HSD11B2, HTR1B, HTR5A, KIT, MAOB, NR3C1, PPARA, PTGS2, SRC | 7.8563 |
| [BP] GO:1902531 | regulation of intracellular signal transduction | AKR1B1, ALOX15, APP, AR, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, DRD2, DYRK1A, ESR1, F3, FLT3, GRM1, HTR2A, HTR2B, HTR2C, HTR6, IGF1R, KDR, KIT, MET, MMP9, PDE5A, PIK3CA, PIK3CB, PRKCA, PTGS2, PTPN1, SRC, XDH | 7.85002 |
| [BP] GO:0007186 | G-protein coupled receptor signaling pathway | ADORA3, APP, CA2, CNR1, CNR2, DRD1, DRD2, ESR1, GRM1, GRM3, GRM5, GRM8, HCAR2, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, PIK3CA, PIK3CB, SRC | 7.80642 |
| [BP] GO:0042981 | regulation of apoptotic process | AKR1B1, APEX1, AR, AURKB, AXL, BCL2, CNR1, CSNK2A1, CYP1B1, ESR1, F3, FLT3, GLO1, GRIK5, HCAR2, HTR2B, IGF1R, KDR, MMP9, PIK3CA, PIK3CB, PIM1, PRKCA, PTGS2, PTPN1, SRC, TERT, TOP2A, XDH | 7.74203 |
| [BP] GO:0019220 | regulation of phosphate metabolic process | ALOX15, APP, AR, BCL2, CDC25B, DRD1, DRD2, FABP4, FLT3, GRM1, GRM3, GRM5, GRM8, HTR1B, HTR1E, HTR2A, HTR2B, HTR2C, IGF1R, KDR, KIT, MMP9, PDE5A, PIK3CA, PIK3CB, PPARA, PRKCA, PTGS2, PTPN1, SRC, XDH | 7.67098 |
| [BP] GO:0051174 | regulation of phosphorus metabolic process | ALOX15, APP, AR, BCL2, CDC25B, DRD1, DRD2, FABP4, FLT3, GRM1, GRM3, GRM5, GRM8, HTR1B, HTR1E, HTR2A, HTR2B, HTR2C, IGF1R, KDR, KIT, MMP9, PDE5A, PIK3CA, PIK3CB, PPARA, PRKCA, PTGS2, PTPN1, SRC, XDH | 7.5889 |
| [BP] GO:0009636 | response to toxic substance | AKR1B1, ALPL, APEX1, AXL, BCL2, CNR1, CNR2, CYP1A1, CYP1B1, DRD1, DRD2, HTR1B, HTR1D, KDR, MAOB, SRC | 7.56567 |
| [BP] GO:0001934 | positive regulation of protein phosphorylation | ALOX15, APP, AR, BCL2, CDC25B, DRD2, FLT3, GRM1, GRM5, HTR2A, HTR2B, HTR2C, KDR, KIT, MMP9, PDE5A, PIK3CA, PIK3CB, PRKCA, PTGS2, PTPN1, SRC, XDH | 7.51968 |
| [BP] GO:0007154 | None | AR, AXL, BCL2, CNR1, DRD1, DRD2, GRIA2, GRIK5, GRM1, GRM3, GRM5, HTR1B, HTR1D, HTR1E, HTR2A, HTR2C, HTR4, HTR6, HTR7, PGR, PTGS2, SLC1A1 | 7.42439 |
| [BP] GO:0007267 | None | AR, CNR1, DRD1, DRD2, GRIA2, GRIK5, GRM1, GRM3, GRM5, HTR1B, HTR1D, HTR1E, HTR2A, HTR2C, HTR4, HTR6, HTR7, PGR, SLC1A1 | 7.40256 |
| [BP] GO:0051173 | positive regulation of nitrogen compound metabolic process | ALOX15, APP, AR, AURKB, BCL2, CDC25B, CSNK2A1, DNMT1, DRD1, DRD2, DYRK1A, ESR1, F3, FLT3, GRM1, GRM5, HTR2A, HTR2B, HTR2C, IGF1R, KDR, KIT, MAOB, MET, MMP12, MMP9, NR3C1, PDE5A, PGR, PIK3CA, PIK3CB, PPARA, PRKCA, PTGS2, PTPN1, RORC, SRC, TERT, TOP2A, XDH | 7.34899 |
| [BP] GO:0008202 | steroid metabolic process | AKR1B1, AKR1B10, APP, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, ESR1, HSD11B1, HSD11B2, HSD17B1, HSD17B2 | 7.24989 |
| [BP] GO:0042327 | positive regulation of phosphorylation | ALOX15, APP, AR, BCL2, CDC25B, DRD2, FLT3, GRM1, GRM5, HTR2A, HTR2B, HTR2C, KDR, KIT, MMP9, PDE5A, PIK3CA, PIK3CB, PRKCA, PTGS2, PTPN1, SRC, XDH | 7.17286 |
| [BP] GO:0010562 | positive regulation of phosphorus metabolic process | ALOX15, APP, AR, BCL2, CDC25B, DRD1, DRD2, FLT3, GRM1, GRM5, HTR2A, HTR2B, HTR2C, KDR, KIT, MMP9, PDE5A, PIK3CA, PIK3CB, PRKCA, PTGS2, PTPN1, SRC, XDH | 7.04352 |
| [BP] GO:0045937 | positive regulation of phosphate metabolic process | ALOX15, APP, AR, BCL2, CDC25B, DRD1, DRD2, FLT3, GRM1, GRM5, HTR2A, HTR2B, HTR2C, KDR, KIT, MMP9, PDE5A, PIK3CA, PIK3CB, PRKCA, PTGS2, PTPN1, SRC, XDH | 7.04352 |
| [BP] GO:0043410 | positive regulation of MAPK cascade | ALOX15, APP, AR, DRD2, FLT3, GRM1, HTR2A, HTR2B, HTR2C, KDR, KIT, PDE5A, PIK3CB, PRKCA, PTPN1, SRC, XDH | 7.0366 |
| [BP] GO:0031401 | positive regulation of protein modification process | ALOX15, APP, AR, BCL2, CDC25B, DNMT1, DRD2, DYRK1A, FLT3, GRM1, GRM5, HTR2A, HTR2B, HTR2C, KDR, KIT, MMP9, PDE5A, PIK3CA, PIK3CB, PRKCA, PTGS2, PTPN1, SRC, XDH | 6.98982 |
| [BP] GO:0007198 | None | HTR1A, HTR1B, HTR5A, HTR7 | 6.90018 |
| [BP] GO:0097756 | None | HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR7, PTGS2 | 6.78212 |
| [BP] GO:0023052 | None | AR, CNR1, DRD1, DRD2, GRIA2, GRIK5, GRM1, GRM3, GRM5, HTR1B, HTR1D, HTR1E, HTR2A, HTR2C, HTR4, HTR6, HTR7, PGR, SLC1A1 | 6.67177 |
| [BP] GO:0048584 | positive regulation of response to stimulus | AKR1B1, ALOX15, APP, AR, AXL, BCL2, CNR1, CSNK2A1, CYP1B1, DRD2, F3, FABP4, FLT3, GRM1, HTR2A, HTR2B, HTR2C, HTR6, KDR, KIT, MET, MMP12, MMP2, MMP9, PDE5A, PIK3CA, PIK3CB, PRKCA, PTGS2, PTPN1, SRC, TERT, XDH | 6.63567 |
| [BP] GO:0048511 | rhythmic process | AXL, BCL2, CSNK2A1, DRD2, DYRK1A, ESR1, HTR7, KIT, PGR, PPARA, RORC, SRC, TOP2A | 6.56972 |
| [BP] GO:0065007 | biological regulation | ABCB1, ACHE, ADORA3, AKR1B1, ALOX15, APEX1, APP, AR, AURKB, AXL, BACE1, BCL2, CA1, CA12, CA2, CA7, CA9, CDC25B, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DNMT1, DRD1, DRD2, DYRK1A, ESR1, F3, FABP4, FLT3, GLO1, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IGF1R, KDR, KIT, MAOB, MET, MMP1, MMP12, MMP2, MMP9, NR3C1, NR3C2, PDE5A, PGR, PIK3CA, PIK3CB, PIM1, PPARA, PRKCA, PTGS1, PTGS2, PTPN1, RORC, SLC1A1, SRC, TERT, TOP2A, XDH | 6.56526 |
| [BP] GO:0001932 | regulation of protein phosphorylation | ALOX15, APP, AR, BCL2, CDC25B, DRD1, DRD2, FABP4, FLT3, GRM1, GRM5, HTR2A, HTR2B, HTR2C, IGF1R, KDR, KIT, MMP9, PDE5A, PIK3CA, PIK3CB, PRKCA, PTGS2, PTPN1, SRC, XDH | 6.55187 |
| [BP] GO:0042445 | hormone metabolic process | ACHE, AKR1B1, CYP19A1, CYP1A1, CYP1B1, CYP3A4, ESR1, HSD11B1, HSD11B2, HSD17B1, HSD17B2 | 6.45451 |
| [BP] GO:0042325 | regulation of phosphorylation | ALOX15, APP, AR, BCL2, CDC25B, DRD1, DRD2, FABP4, FLT3, GRM1, GRM5, HTR2A, HTR2B, HTR2C, IGF1R, KDR, KIT, MMP9, PDE5A, PIK3CA, PIK3CB, PPARA, PRKCA, PTGS2, PTPN1, SRC, XDH | 6.45451 |
| [BP] GO:0051247 | positive regulation of protein metabolic process | ALOX15, APP, AR, BCL2, CDC25B, CSNK2A1, DNMT1, DRD2, DYRK1A, ESR1, F3, FLT3, GRM1, GRM5, HTR2A, HTR2B, HTR2C, KDR, KIT, MMP9, PDE5A, PIK3CA, PIK3CB, PRKCA, PTGS2, PTPN1, SRC, XDH | 6.43963 |
| [BP] GO:0015701 | bicarbonate transport | CA1, CA12, CA14, CA2, CA4, CA7, CA9 | 6.43906 |
| [BP] GO:0051049 | regulation of transport | ABCB1, ACHE, ALOX15, APP, AXL, BCL2, CA2, CA7, CNR1, CYP19A1, DRD1, DRD2, GRIK5, GRM5, HCAR2, HTR1A, HTR1B, HTR2A, HTR2B, HTR2C, MAOB, MMP12, MMP9, PIK3CB, PPARA, PRKCA, PTGS2, PTPN1, SRC, TERT | 6.41544 |
| [BP] GO:0031325 | positive regulation of cellular metabolic process | ALOX15, APP, AR, AURKB, BCL2, CDC25B, DNMT1, DRD1, DRD2, DYRK1A, ESR1, F3, FLT3, GRM1, GRM5, HTR2A, HTR2B, HTR2C, IGF1R, KDR, KIT, MAOB, MET, MMP12, MMP9, NR3C1, PDE5A, PGR, PIK3CA, PIK3CB, PPARA, PRKCA, PTGS2, PTPN1, RORC, SRC, TERT, TOP2A, XDH | 6.35361 |
| [BP] GO:0051716 | cellular response to stimulus | AKR1B1, ALOX15, ALPL, APEX1, APP, AR, AURKB, AXL, BCL2, CA2, CA9, CYP1A1, CYP1A2, CYP1B1, DNMT1, DRD1, ESR1, FABP4, FLT3, GRIK5, GRM1, GRM5, HTR1B, IGF1R, KDR, KIT, MMP2, MMP9, NR3C1, PIK3CA, PTGS2, PTPN1, RORC, SRC, TERT, TOP2A | 6.35203 |
| [BP] GO:0032270 | positive regulation of cellular protein metabolic process | ALOX15, APP, AR, BCL2, CDC25B, DNMT1, DRD2, DYRK1A, ESR1, F3, FLT3, GRM1, GRM5, HTR2A, HTR2B, HTR2C, KDR, KIT, MMP9, PDE5A, PIK3CA, PIK3CB, PRKCA, PTGS2, PTPN1, SRC, XDH | 6.31207 |
| [BP] GO:0010604 | positive regulation of macromolecule metabolic process | ALOX15, APP, AR, AURKB, BCL2, CDC25B, CSNK2A1, DNMT1, DRD1, DRD2, DYRK1A, ESR1, F3, FLT3, GRM1, GRM5, HTR2A, HTR2B, HTR2C, IGF1R, KDR, KIT, MET, MMP12, MMP9, NR3C1, PDE5A, PGR, PIK3CA, PIK3CB, PPARA, PRKCA, PTGS2, PTPN1, RORC, SRC, TERT, TOP2A, XDH | 6.29936 |
| [BP] GO:1901701 | cellular response to oxygen-containing compound | AKR1B1, APEX1, APP, AR, AXL, CYP1B1, DNMT1, DRD1, ESR1, GRIK5, GRM5, IGF1R, MMP2, MMP9, NR3C1, PIK3CA, PTGS2, RORC, SRC | 6.18925 |
| [BP] GO:0032502 | developmental process | ACHE, AKR1B1, ALOX15, ALPL, APEX1, APP, AR, AURKB, AXL, BCL2, CA2, CA9, CDC25B, CNR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DYRK1A, ESR1, FABP4, FLT3, FUT7, GLO1, HSD11B1, HSD17B2, HTR2A, HTR2B, HTR5A, KDR, KIT, MAOB, MET, MMP2, MMP9, PGR, PIK3CA, PIK3CB, PIM1, PPARA, PRKCA, PTGS2, RORC, SRC, TERT, TOP2A, TYR | 6.06321 |
| [BP] GO:0060548 | negative regulation of cell death | AKR1B1, AR, AURKB, AXL, BCL2, CSNK2A1, GLO1, HTR2B, IGF1R, KDR, KIT, MET, MMP9, PIK3CA, PIM1, PPARA, PRKCA, PTGS2, PTPN1, SRC, TERT | 6.04975 |
| [BP] GO:0042592 | homeostatic process | AKR1B1, APEX1, APP, AXL, BCL2, CA12, CA2, CA7, CNR1, DRD1, DRD2, ESR1, FABP4, FLT3, GRIK5, GRM1, GRM5, HTR2A, HTR2B, HTR2C, MET, PIK3CA, PIK3CB, SRC, TERT | 6.03072 |
| [BP] GO:0010038 | response to metal ion | ALOX15, APP, BCL2, CA2, CYP1A1, CYP1A2, DRD2, FABP4, KIT, MAOB, MMP9, PTGS2, TERT | 6.03072 |
| [BP] GO:0042310 | None | HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR7 | 6.02841 |
| [BP] GO:0019748 | secondary metabolic process | AKR1B1, AKR1B10, BCL2, CYP1A1, CYP1A2, CYP1B1, TYR | 6.02297 |
| [BP] GO:0009893 | positive regulation of metabolic process | ALOX15, APP, AR, AURKB, BCL2, CDC25B, CSNK2A1, DNMT1, DRD1, DRD2, DYRK1A, ESR1, F3, FLT3, GRM1, GRM5, HTR2A, HTR2B, HTR2C, IGF1R, KDR, KIT, MAOB, MET, MMP12, MMP9, NR3C1, PDE5A, PGR, PIK3CA, PIK3CB, PPARA, PRKCA, PTGS2, PTPN1, RORC, SRC, TERT, TOP2A, XDH | 5.98792 |
| [BP] GO:0043069 | negative regulation of programmed cell death | AKR1B1, AR, AURKB, AXL, BCL2, CSNK2A1, GLO1, HTR2B, IGF1R, KDR, KIT, MET, MMP9, PIK3CA, PIM1, PRKCA, PTGS2, PTPN1, SRC, TERT | 5.98461 |
| [BP] GO:0044281 | small molecule metabolic process | AKR1B1, AKR1B10, ALOX15, ALOX5, APP, CA1, CA12, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, FUT7, GLO1, HTR2B, HTR2C, PDE5A, PIK3CA, PIM1, PPARA, PTGS1, PTGS2, TYR, XDH | 5.95164 |
| [BP] GO:0006796 | phosphate-containing compound metabolic process | ACHE, ALOX15, ALPI, ALPL, APEX1, APP, AURKB, AXL, BCL2, CDC25B, CSNK2A1, DRD1, DRD2, DYRK1A, FLT3, HTR2B, HTR2C, IGF1R, KDR, KIT, MET, PDE5A, PIK3CA, PIK3CB, PIM1, PRKCA, PTGS2, PTPN1, SRC, XDH | 5.92835 |
| [BP] GO:0048519 | negative regulation of biological process | ACHE, ADORA3, AKR1B1, ALOX15, APEX1, APP, AR, AURKB, AXL, BCL2, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1B1, DNMT1, DRD1, DRD2, DYRK1A, ESR1, FABP4, GLO1, GRM3, GRM8, HCAR2, HTR1B, HTR1E, HTR2A, HTR2B, HTR2C, IGF1R, KDR, KIT, MAOB, MET, MMP12, MMP9, NR3C1, PDE5A, PGR, PIK3CA, PIM1, PPARA, PRKCA, PTGS2, PTPN1, RORC, SRC, TERT, TOP2A, XDH | 5.79583 |
| [BP] GO:0032844 | regulation of homeostatic process | AURKB, BCL2, CA2, CA7, CNR1, DRD1, DRD2, HCAR2, HTR2A, HTR2B, HTR2C, KDR, PIK3CB, PTGS2, SRC | 5.78708 |
| [BP] GO:0032228 | regulation of synaptic transmission, GABAergic | CA2, CA7, CNR1, CNR2, DRD2, HTR1B | 5.78708 |
| [BP] GO:0055114 | oxidation-reduction process | AKR1B1, AKR1B10, ALOX15, ALOX5, APEX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, HSD11B1, HSD11B2, HSD17B1, HSD17B2, MAOB, NQO2, PTGS1, PTGS2, TYR, XDH | 5.78708 |
| [BP] GO:0048545 | response to steroid hormone | ALPL, AR, BCL2, CA2, FLT3, HSD11B2, HTR1B, MAOB, NR3C1, PTGS2, SRC | 5.78708 |
| [BP] GO:0008610 | lipid biosynthetic process | ACHE, AKR1B1, ALOX15, ALPI, CSNK2A1, CYP19A1, CYP1A1, CYP3A4, HSD11B1, HSD11B2, HSD17B1, HSD17B2, PIK3CA, PIK3CB, PTGS1, PTGS2 | 5.78127 |
| [BP] GO:0043408 | regulation of MAPK cascade | ALOX15, APP, AR, DRD2, FLT3, GRM1, HTR2A, HTR2B, HTR2C, IGF1R, KDR, KIT, PDE5A, PIK3CB, PRKCA, PTPN1, SRC, XDH | 5.77962 |
| [BP] GO:0048523 | negative regulation of cellular process | ACHE, ADORA3, AKR1B1, APEX1, APP, AR, AURKB, AXL, BCL2, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1B1, DNMT1, DRD1, DRD2, DYRK1A, ESR1, FABP4, GLO1, GRM3, GRM8, HTR1B, HTR1E, HTR2A, HTR2B, HTR2C, IGF1R, KDR, KIT, MAOB, MET, MMP12, MMP9, NR3C1, PDE5A, PIK3CA, PIM1, PPARA, PRKCA, PTGS2, PTPN1, RORC, SRC, TERT, TOP2A, XDH | 5.7063 |
| [BP] GO:0031399 | regulation of protein modification process | ALOX15, APP, AR, BCL2, CDC25B, DNMT1, DRD1, DRD2, DYRK1A, FABP4, FLT3, GRM1, GRM5, HTR2A, HTR2B, HTR2C, IGF1R, KDR, KIT, MMP9, PDE5A, PIK3CA, PIK3CB, PRKCA, PTGS2, PTPN1, SRC, XDH | 5.69003 |
| [BP] GO:1901615 | organic hydroxy compound metabolic process | AKR1B1, AKR1B10, ALOX15, APP, BCL2, CYP19A1, CYP1A1, CYP1B1, CYP3A4, DRD1, DRD2, HTR1A, MAOB, TYR | 5.67141 |
| [BP] GO:0071407 | cellular response to organic cyclic compound | ALPL, APEX1, APP, AR, CYP1A1, CYP1B1, DRD1, ESR1, FLT3, NR3C1, PTGS2, RORC, SRC | 5.60658 |
| [BP] GO:0050790 | regulation of catalytic activity | ADORA3, APP, AR, AURKB, BCL2, CDC25B, CNR1, CNR2, CSNK2A1, DRD1, DRD2, ESR1, F3, FABP4, FLT3, GRM1, GRM3, GRM5, HTR2A, HTR2B, IGF1R, KIT, MMP9, PDE5A, PIK3CA, PIK3CB, PRKCA, PTGS2, PTPN1, SRC, TERT, XDH | 5.56985 |
| [BP] GO:0042446 | hormone biosynthetic process | AKR1B1, CYP19A1, CYP3A4, HSD11B1, HSD11B2, HSD17B1, HSD17B2 | 5.53361 |
| [BP] GO:0006793 | phosphorus metabolic process | ACHE, ALOX15, ALPI, ALPL, APEX1, APP, AURKB, AXL, BCL2, CDC25B, CSNK2A1, DRD1, DRD2, DYRK1A, FLT3, HTR2B, HTR2C, IGF1R, KDR, KIT, MET, PDE5A, PIK3CA, PIK3CB, PIM1, PRKCA, PTGS2, PTPN1, SRC, XDH | 5.52683 |
| [BP] GO:0006730 | one-carbon metabolic process | CA1, CA12, CA2, CA4, CA7, CA9 | 5.50728 |
| [BP] GO:0048878 | chemical homeostasis | AKR1B1, APP, BCL2, CA12, CA2, CA7, CNR1, DRD1, DRD2, ESR1, FABP4, GRIK5, GRM1, GRM5, HTR2A, HTR2B, HTR2C, MET, PIK3CA, PIK3CB | 5.44711 |
| [BP] GO:0010243 | response to organonitrogen compound | AKR1B1, APEX1, APP, CNR1, CNR2, DNMT1, DRD1, DRD2, FLT3, GRM5, HSD11B2, HTR1B, IGF1R, MMP2, PPARA, PTGS2, SRC, TYR | 5.43118 |
| [BP] GO:0050805 | negative regulation of synaptic transmission | ACHE, CNR2, DRD1, DRD2, HTR1B, HTR2A, PTGS2 | 5.40415 |
| [BP] GO:0050795 | None | CNR1, DRD2, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B | 5.40415 |
| [BP] GO:0030334 | regulation of cell migration | ADORA3, APEX1, APP, BCL2, CYP19A1, CYP1B1, DRD1, DRD2, F3, IGF1R, KDR, KIT, MET, MMP9, PRKCA, PTGS2, SRC, TERT | 5.33696 |
| [BP] GO:0044255 | cellular lipid metabolic process | ACHE, AKR1B10, ALOX15, ALOX5, ALPI, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD2, FABP4, FUT7, KIT, MET, PIK3CA, PIK3CB, PPARA, PTGS1, PTGS2 | 5.3122 |
| [BP] GO:0003008 | None | AKR1B1, APP, BCL2, CNR1, CNR2, CYP1B1, DRD1, DRD2, GRM1, GRM5, GRM8, HSD11B2, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR7, KIT, PDE5A, PIK3CA, PTGS2, SRC, TYR | 5.29897 |
| [BP] GO:0019222 | regulation of metabolic process | ACHE, ADORA3, ALOX15, APEX1, APP, AR, AURKB, BCL2, CA9, CDC25B, CNR1, CNR2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DNMT1, DRD1, DRD2, DYRK1A, ESR1, F3, FABP4, FLT3, GLO1, GRM1, GRM3, GRM5, GRM8, HCAR2, HTR1A, HTR1B, HTR1E, HTR2A, HTR2B, HTR2C, IGF1R, KDR, KIT, MAOB, MET, MMP12, MMP9, NR3C1, NR3C2, PDE5A, PGR, PIK3CA, PIK3CB, PIM1, PPARA, PRKCA, PTGS2, PTPN1, RORC, SRC, TERT, TOP2A, XDH | 5.14686 |
| [BP] GO:0040012 | regulation of locomotion | ADORA3, APEX1, APP, BCL2, CYP19A1, CYP1B1, DRD1, DRD2, F3, HTR1D, IGF1R, KDR, KIT, MET, MMP9, PRKCA, PTGS2, SRC, TERT | 5.14573 |
| [BP] GO:0080090 | regulation of primary metabolic process | ADORA3, ALOX15, APEX1, APP, AR, AURKB, BCL2, CA9, CDC25B, CNR1, CSNK2A1, CYP1A1, CYP1B1, DNMT1, DRD1, DRD2, DYRK1A, ESR1, F3, FABP4, FLT3, GLO1, GRM1, GRM3, GRM5, GRM8, HCAR2, HTR1A, HTR1B, HTR1E, HTR2A, HTR2B, HTR2C, IGF1R, KDR, KIT, MAOB, MET, MMP12, MMP9, NR3C1, NR3C2, PDE5A, PGR, PIK3CA, PIK3CB, PIM1, PPARA, PRKCA, PTGS2, PTPN1, RORC, SRC, TERT, TOP2A, XDH | 5.14573 |
| [BP] GO:0007610 | None | APP, BCL2, CNR1, DRD1, DRD2, GRM1, GRM5, HTR1A, HTR1B, HTR2A, HTR2B, HTR2C, KIT, PPARA, PTGS2 | 5.13384 |
| [BP] GO:1900543 | None | DRD2, GRM3, GRM8, HTR1B, HTR1E, PPARA, PRKCA | 5.10954 |
| [BP] GO:0034754 | cellular hormone metabolic process | AKR1B1, CYP19A1, CYP1A1, CYP1B1, CYP3A4, ESR1, HSD17B1, HSD17B2 | 5.09844 |
| [BP] GO:0045980 | None | DRD2, GRM3, GRM8, HTR1B, HTR1E, PPARA, PRKCA | 5.07262 |
| [BP] GO:1903727 | positive regulation of phospholipid metabolic process | FLT3, HTR2A, HTR2B, HTR2C, KIT, SRC | 5.06875 |
| [BP] GO:0009628 | response to abiotic stimulus | AKR1B1, APP, AURKB, BCL2, CA2, CYP1A1, DRD1, DRD2, GRM1, HSD11B2, HTR1B, HTR2A, HTR2B, KIT, MMP2, PPARA, PTGS2, SRC, TERT, TYR | 5.05919 |
| [BP] GO:0031960 | response to corticosteroid | ALPL, BCL2, FLT3, HSD11B2, HTR1B, MAOB, NR3C1, PTGS2, SRC | 5.042 |
| [BP] GO:0003018 | None | DRD1, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR7, PTGS2, SRC | 5.042 |
| [BP] GO:0007196 | None | GRM1, GRM3, GRM5, GRM8 | 5.042 |
| [BP] GO:2000021 | regulation of ion homeostasis | BCL2, CA2, CA7, DRD1, DRD2, HTR2A, HTR2B, HTR2C, KDR, SRC | 5.0159 |
| [BP] GO:1901698 | response to nitrogen compound | AKR1B1, APEX1, APP, CNR1, CNR2, DNMT1, DRD1, DRD2, FLT3, GRM5, HSD11B2, HTR1B, IGF1R, MMP2, PPARA, PTGS2, SRC, TYR | 4.98018 |
| [BP] GO:0048583 | regulation of response to stimulus | ABCB1, AKR1B1, ALOX15, APP, AR, AURKB, AXL, BCL2, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DYRK1A, ESR1, F3, FABP4, FLT3, GRM1, HTR1B, HTR2A, HTR2B, HTR2C, HTR6, IGF1R, KDR, KIT, MET, MMP12, MMP2, MMP9, PDE5A, PIK3CA, PIK3CB, PPARA, PRKCA, PTGS2, PTPN1, SRC, TERT, XDH | 4.97462 |
| [BP] GO:2000145 | regulation of cell motility | ADORA3, APEX1, APP, BCL2, CYP19A1, CYP1B1, DRD1, DRD2, F3, IGF1R, KDR, KIT, MET, MMP9, PRKCA, PTGS2, SRC, TERT | 4.97252 |
| [BP] GO:0018958 | None | AKR1B1, BCL2, DRD1, DRD2, HTR1A, MAOB, TYR | 4.85976 |
| [BP] GO:2001225 | regulation of chloride transport | ABCB1, CA2, CA7, GRM5 | 4.84083 |
| [BP] GO:0008152 | metabolic process | ACHE, AKR1B1, AKR1B10, ALOX15, ALOX5, ALPI, ALPL, APEX1, APP, AR, AURKB, AXL, BACE1, BCL2, CA1, CA12, CA2, CA4, CA7, CA9, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DNMT1, DRD1, DRD2, DYRK1A, ESR1, F3, FABP4, FLT3, FUT7, GLO1, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HTR1A, HTR1B, HTR2B, HTR2C, IGF1R, KDR, KIT, MAOB, MET, MMP1, MMP12, MMP2, MMP9, NQO2, NR3C1, NR3C2, PDE5A, PGR, PIK3CA, PIK3CB, PIM1, PPARA, PRKCA, PTGS1, PTGS2, PTPN1, RORC, SRC, TERT, TOP2A, TYR, XDH | 4.81475 |
| [BP] GO:0030815 | None | DRD2, GRM3, GRM8, HTR1B, HTR1E, PRKCA | 4.81168 |
| [BP] GO:0006939 | None | DRD1, DRD2, HTR1D, HTR2A, HTR2B, HTR7 | 4.81168 |
| [BP] GO:0009892 | negative regulation of metabolic process | APEX1, APP, AR, AURKB, BCL2, CNR1, CNR2, CSNK2A1, DNMT1, DRD2, DYRK1A, ESR1, FABP4, GRM3, GRM8, HCAR2, HTR1B, HTR1E, HTR2B, IGF1R, KDR, MET, MMP12, MMP9, NR3C1, PGR, PIK3CA, PPARA, PRKCA, PTGS2, PTPN1, RORC, SRC, TERT, XDH | 4.77598 |
| [BP] GO:0043066 | negative regulation of apoptotic process | AKR1B1, AR, AURKB, AXL, BCL2, CSNK2A1, GLO1, HTR2B, IGF1R, KDR, MMP9, PIK3CA, PIM1, PRKCA, PTGS2, PTPN1, SRC, TERT | 4.74403 |
| [BP] GO:0030800 | None | DRD2, GRM3, GRM8, HTR1B, HTR1E, PRKCA | 4.71497 |
| [BP] GO:0045834 | positive regulation of lipid metabolic process | FLT3, HTR2A, HTR2B, HTR2C, KIT, PPARA, PTGS2, SRC | 4.71497 |
| [BP] GO:0097746 | None | DRD1, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR7, PTGS2 | 4.69277 |
| [BP] GO:0035296 | None | DRD1, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR7, PTGS2 | 4.69277 |
| [BP] GO:0071495 | cellular response to endogenous stimulus | AKR1B1, APEX1, APP, AR, DNMT1, DRD1, ESR1, FLT3, GRM5, HTR1B, IGF1R, KIT, MMP2, NR3C1, PTGS2, SRC | 4.6489 |
| [BP] GO:0009987 | cellular process | ABCB1, ACHE, ADORA3, AKR1B1, AKR1B10, ALOX15, ALOX5, ALPI, ALPL, APEX1, APP, AR, AURKB, AXL, BACE1, BCL2, CA1, CA12, CA2, CA4, CA7, CA9, CDC25B, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DNMT1, DRD1, DRD2, DYRK1A, ESR1, F3, FABP4, FLT3, FUT7, GLO1, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, HSD17B1, HSD17B2, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IGF1R, KDR, KIT, MAOB, MET, MMP1, MMP12, MMP2, MMP9, NQO2, NR3C1, NR3C2, PDE5A, PGR, PIK3CA, PIK3CB, PIM1, PPARA, PRKCA, PTGS1, PTGS2, PTPN1, RORC, SLC1A1, SRC, TERT, TOP2A, TYR, XDH | 4.6489 |
| [BP] GO:0019216 | regulation of lipid metabolic process | CNR1, CYP1A1, FLT3, HCAR2, HTR2A, HTR2B, HTR2C, KIT, PPARA, PTGS2, RORC, SRC | 4.6203 |
| [BP] GO:1900542 | None | DRD1, DRD2, GRM3, GRM8, HTR1B, HTR1E, HTR2A, PDE5A, PPARA, PRKCA | 4.59544 |
| [BP] GO:0007200 | None | DRD1, DRD2, ESR1, GRM5, HTR2A, HTR2B, HTR2C | 4.57658 |
| [BP] GO:0030335 | positive regulation of cell migration | APP, BCL2, DRD1, F3, IGF1R, KDR, KIT, MET, MMP9, PRKCA, PTGS2, SRC, TERT | 4.57658 |
| [BP] GO:0051240 | positive regulation of multicellular organismal process | APP, AR, AXL, BCL2, CA2, CNR1, CYP1B1, DRD2, F3, HCAR2, HTR2A, HTR2B, KDR, KIT, MET, MMP12, MMP9, PDE5A, PIM1, PRKCA, PTGS2, SLC1A1, SRC, TERT | 4.57658 |
| [BP] GO:0043401 | steroid hormone mediated signaling pathway | AR, ESR1, NR3C1, NR3C2, PGR, PPARA, RORC, SRC | 4.55862 |
| [BP] GO:0043269 | regulation of ion transport | ABCB1, APP, BCL2, CA2, CA7, CNR1, DRD1, DRD2, GRM5, HTR1A, HTR1B, HTR2A, MAOB, MMP9, PTGS2 | 4.55257 |
| [BP] GO:0019369 | arachidonic acid metabolic process | ALOX15, CYP1A1, CYP1A2, CYP1B1, PTGS1, PTGS2 | 4.54575 |
| [BP] GO:0050789 | regulation of biological process | ABCB1, ACHE, ADORA3, AKR1B1, ALOX15, APEX1, APP, AR, AURKB, AXL, BACE1, BCL2, CA1, CA2, CA7, CA9, CDC25B, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DNMT1, DRD1, DRD2, DYRK1A, ESR1, F3, FABP4, FLT3, GLO1, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IGF1R, KDR, KIT, MAOB, MET, MMP1, MMP12, MMP2, MMP9, NR3C1, NR3C2, PDE5A, PGR, PIK3CA, PIK3CB, PIM1, PPARA, PRKCA, PTGS1, PTGS2, PTPN1, RORC, SLC1A1, SRC, TERT, TOP2A, XDH | 4.53506 |
| [BP] GO:0050880 | None | DRD1, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR7, PTGS2 | 4.51926 |
| [BP] GO:0051270 | regulation of cellular component movement | ADORA3, APEX1, APP, BCL2, CYP19A1, CYP1B1, DRD1, DRD2, F3, IGF1R, KDR, KIT, MET, MMP9, PRKCA, PTGS2, SRC, TERT | 4.50923 |
| [BP] GO:0006140 | None | DRD1, DRD2, GRM3, GRM8, HTR1B, HTR1E, HTR2A, PDE5A, PPARA, PRKCA | 4.50292 |
| [BP] GO:0035150 | None | DRD1, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR7, PTGS2 | 4.50262 |
| [BP] GO:0051588 | None | DRD1, DRD2, GRIK5, HTR1A, HTR1B, HTR2C, MAOB | 4.50262 |
| [BP] GO:2000147 | positive regulation of cell motility | APP, BCL2, DRD1, F3, IGF1R, KDR, KIT, MET, MMP9, PRKCA, PTGS2, SRC, TERT | 4.43074 |
| [BP] GO:0031323 | regulation of cellular metabolic process | ACHE, ADORA3, ALOX15, APEX1, APP, AR, AURKB, BCL2, CA9, CDC25B, CNR1, CSNK2A1, CYP1B1, DNMT1, DRD1, DRD2, DYRK1A, ESR1, F3, FABP4, FLT3, GLO1, GRM1, GRM3, GRM5, GRM8, HTR1A, HTR1B, HTR1E, HTR2A, HTR2B, HTR2C, IGF1R, KDR, KIT, MAOB, MET, MMP12, MMP9, NR3C1, NR3C2, PDE5A, PGR, PIK3CA, PIK3CB, PIM1, PPARA, PRKCA, PTGS2, PTPN1, RORC, SRC, TERT, TOP2A, XDH | 4.4164 |
| [BP] GO:0044237 | cellular metabolic process | ACHE, AKR1B1, AKR1B10, ALOX15, ALOX5, ALPI, ALPL, APEX1, APP, AR, AURKB, AXL, BACE1, BCL2, CA1, CA12, CA2, CA4, CA7, CA9, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DNMT1, DRD1, DRD2, DYRK1A, ESR1, FABP4, FLT3, FUT7, GLO1, HSD17B1, HSD17B2, HTR1A, HTR1B, HTR2B, HTR2C, IGF1R, KDR, KIT, MAOB, MET, MMP1, MMP2, NQO2, NR3C1, NR3C2, PDE5A, PGR, PIK3CA, PIK3CB, PIM1, PPARA, PRKCA, PTGS1, PTGS2, PTPN1, RORC, SRC, TERT, TOP2A, TYR, XDH | 4.40188 |
| [BP] GO:0014065 | phosphatidylinositol 3-kinase signaling | HTR2A, HTR2B, IGF1R, PIK3CA, PIK3CB | 4.38477 |
| [BP] GO:0065009 | regulation of molecular function | ABCB1, ADORA3, APP, AR, AURKB, BCL2, CDC25B, CNR1, CNR2, CSNK2A1, CYP1B1, DRD1, DRD2, ESR1, F3, FABP4, FLT3, GRM1, GRM3, GRM5, HTR2A, HTR2B, IGF1R, KIT, MET, MMP9, PDE5A, PIK3CA, PIK3CB, PIM1, PPARA, PRKCA, PTGS2, PTPN1, SRC, TERT, XDH | 4.35693 |
| [BP] GO:0043271 | negative regulation of ion transport | BCL2, CNR1, DRD2, HTR1B, HTR2A, MAOB, MMP9, PTGS2 | 4.32852 |
| [BP] GO:0032847 | regulation of cellular pH reduction | BCL2, CA2, CA7 | 4.31916 |
| [BP] GO:0051272 | positive regulation of cellular component movement | APP, BCL2, DRD1, F3, IGF1R, KDR, KIT, MET, MMP9, PRKCA, PTGS2, SRC, TERT | 4.31149 |
| [BP] GO:0030799 | None | DRD1, DRD2, GRM3, GRM8, HTR1B, HTR1E, PDE5A, PRKCA | 4.31149 |
| [BP] GO:0033559 | unsaturated fatty acid metabolic process | ALOX15, ALOX5, CYP1A1, CYP1A2, CYP1B1, PTGS1, PTGS2 | 4.30769 |
| [BP] GO:0046777 | protein autophosphorylation | AURKB, CSNK2A1, DYRK1A, FLT3, IGF1R, KDR, KIT, PIM1, SRC | 4.29477 |
| [BP] GO:0070374 | positive regulation of ERK1 and ERK2 cascade | ALOX15, APP, DRD2, HTR2A, HTR2B, HTR2C, KDR, PRKCA, SRC | 4.27829 |
| [BP] GO:0007216 | None | GRM1, GRM3, GRM5, GRM8 | 4.27498 |
| [BP] GO:0006468 | protein phosphorylation | APP, AURKB, AXL, BCL2, CDC25B, CSNK2A1, DRD1, DYRK1A, FLT3, HTR2B, IGF1R, KDR, KIT, MET, PIK3CA, PIM1, PRKCA, SRC | 4.2552 |
| [BP] GO:0051171 | regulation of nitrogen compound metabolic process | ADORA3, ALOX15, APEX1, APP, AR, AURKB, BCL2, CA9, CDC25B, CSNK2A1, CYP1B1, DNMT1, DRD1, DRD2, DYRK1A, ESR1, F3, FABP4, FLT3, GLO1, GRM1, GRM3, GRM5, GRM8, HTR1A, HTR1B, HTR1E, HTR2A, HTR2B, HTR2C, IGF1R, KDR, KIT, MAOB, MET, MMP12, MMP9, NR3C1, NR3C2, PDE5A, PGR, PIK3CA, PIK3CB, PIM1, PPARA, PRKCA, PTGS2, PTPN1, RORC, SRC, TERT, TOP2A, XDH | 4.25211 |
| [BP] GO:0050794 | regulation of cellular process | ACHE, ADORA3, AKR1B1, ALOX15, APEX1, APP, AR, AURKB, AXL, BACE1, BCL2, CA1, CA2, CA7, CA9, CDC25B, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DNMT1, DRD1, DRD2, DYRK1A, ESR1, F3, FABP4, FLT3, GLO1, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IGF1R, KDR, KIT, MAOB, MET, MMP1, MMP12, MMP2, MMP9, NR3C1, NR3C2, PDE5A, PGR, PIK3CA, PIK3CB, PIM1, PPARA, PRKCA, PTGS1, PTGS2, PTPN1, RORC, SRC, TERT, TOP2A, XDH | 4.23914 |
| [BP] GO:0055082 | cellular chemical homeostasis | APP, BCL2, CA2, CA7, DRD1, DRD2, ESR1, GRIK5, GRM1, GRM5, HTR2A, HTR2B, HTR2C, PIK3CA, PIK3CB | 4.22512 |
| [BP] GO:0008283 | cell proliferation | ABCB1, ACHE, AR, AURKB, BCL2, CYP1A1, ESR1, FLT3, HTR1A, KIT, MET, PIK3CB, PIM1, SRC, TYR | 4.21879 |
| [BP] GO:0040017 | positive regulation of locomotion | APP, BCL2, DRD1, F3, IGF1R, KDR, KIT, MET, MMP9, PRKCA, PTGS2, SRC, TERT | 4.1658 |
| [BP] GO:0044092 | negative regulation of molecular function | ADORA3, APP, AURKB, CNR1, CNR2, CSNK2A1, CYP1B1, DRD2, ESR1, FABP4, GRM3, IGF1R, MET, MMP9, PIM1, PPARA, PRKCA, PTGS2, PTPN1, SRC | 4.16148 |
| [BP] GO:0003013 | None | DRD1, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR7, PTGS2, SRC | 4.15779 |
| [BP] GO:0006690 | icosanoid metabolic process | ALOX15, ALOX5, CYP1A1, CYP1A2, CYP1B1, PTGS1, PTGS2 | 4.1319 |
| [BP] GO:0007169 | transmembrane receptor protein tyrosine kinase signaling pathway | AXL, FLT3, IGF1R, KDR, KIT, MET, MMP2, MMP9, PIK3CA, PIK3CB, PRKCA, PTPN1, SRC | 4.0652 |
| [BP] GO:0070372 | regulation of ERK1 and ERK2 cascade | ALOX15, APP, DRD2, HTR2A, HTR2B, HTR2C, KDR, PRKCA, PTPN1, SRC | 4.06271 |
| [BP] GO:0051896 | regulation of protein kinase B signaling | AXL, DRD2, F3, KIT, MET, PIK3CA, PIK3CB, SRC, XDH | 4.06271 |
| [BP] GO:1903530 | regulation of secretion by cell | ACHE, CNR1, CYP19A1, DRD2, GRIK5, HCAR2, HTR1A, HTR1B, HTR2A, HTR2B, HTR2C, MAOB, MMP12, PRKCA, SRC | 4.01258 |
| [BP] GO:0010513 | None | HTR2A, HTR2B, HTR2C | 3.97343 |
| [BP] GO:0035690 | cellular response to drug | AKR1B1, APEX1, AXL, CYP1B1, DRD1, HTR1B, KDR, NR3C1, PTGS2, SRC | 3.96036 |
| [BP] GO:0019725 | cellular homeostasis | APEX1, APP, BCL2, CA2, CA7, DRD1, DRD2, ESR1, GRIK5, GRM1, GRM5, HTR2A, HTR2B, HTR2C, PIK3CA, PIK3CB | 3.95084 |
| [BP] GO:0045860 | positive regulation of protein kinase activity | CDC25B, DRD2, FLT3, GRM1, GRM5, HTR2A, HTR2B, KIT, PDE5A, PIK3CA, PIK3CB, PTPN1, SRC | 3.94095 |
| [BP] GO:0045859 | regulation of protein kinase activity | APP, CDC25B, DRD2, FABP4, FLT3, GRM1, GRM5, HTR2A, HTR2B, IGF1R, KIT, PDE5A, PIK3CA, PIK3CB, PTPN1, SRC | 3.93303 |
| [BP] GO:1903725 | regulation of phospholipid metabolic process | FLT3, HTR2A, HTR2B, HTR2C, KIT, SRC | 3.89475 |
| [BP] GO:0006805 | xenobiotic metabolic process | CYP1A1, CYP1A2, CYP1B1, CYP3A4, NQO2, PTGS1, RORC | 3.8887 |
| [BP] GO:0014821 | None | DRD1, DRD2, HTR1D, HTR2B | 3.84918 |
| [BP] GO:0030814 | None | DRD1, DRD2, GRM3, GRM8, HTR1B, HTR1E, PRKCA | 3.84297 |
| [BP] GO:0009755 | hormone-mediated signaling pathway | AR, ESR1, NR3C1, NR3C2, PGR, PPARA, RORC, SRC | 3.84297 |
| [BP] GO:0032846 | positive regulation of homeostatic process | AURKB, CA2, CA7, CNR1, DRD1, DRD2, HCAR2, PIK3CB, PTGS2 | 3.84169 |
| [BP] GO:0009966 | regulation of signal transduction | AKR1B1, ALOX15, APP, AR, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, DRD2, DYRK1A, ESR1, F3, FLT3, GRM1, HTR2A, HTR2B, HTR2C, HTR6, IGF1R, KDR, KIT, MET, MMP12, MMP9, PDE5A, PIK3CA, PIK3CB, PRKCA, PTGS2, PTPN1, SRC, TERT, XDH | 3.84089 |
| [BP] GO:0022414 | reproductive process | AKR1B1, ALPL, APP, AR, AXL, BCL2, CDC25B, CNR1, CYP19A1, CYP1A1, DRD1, ESR1, HSD11B2, HSD17B2, KIT, MMP2, MMP9, PGR, PTGS2, SRC, TOP2A | 3.79205 |
| [BP] GO:0048661 | positive regulation of smooth muscle cell proliferation | AKR1B1, HTR1B, MMP2, MMP9, PTGS2, TERT | 3.77209 |
| [BP] GO:0030522 | intracellular receptor signaling pathway | AR, ESR1, NR3C1, PGR, PIM1, PPARA, RORC, SRC | 3.70373 |
| [BP] GO:0044093 | positive regulation of molecular function | ABCB1, APP, AR, AURKB, BCL2, CDC25B, DRD2, ESR1, F3, FLT3, GRM1, GRM5, HTR2A, HTR2B, KIT, MET, MMP9, PDE5A, PIK3CA, PIK3CB, PTPN1, SRC, TERT, XDH | 3.70373 |
| [BP] GO:0030818 | None | DRD2, GRM3, GRM8, HTR1B, PRKCA | 3.69292 |
| [BP] GO:0006874 | cellular calcium ion homeostasis | APP, BCL2, DRD1, DRD2, ESR1, GRM1, GRM5, HTR2A, HTR2B, HTR2C, PIK3CB | 3.67097 |
| [BP] GO:0031324 | negative regulation of cellular metabolic process | APEX1, APP, AR, AURKB, BCL2, CNR1, CSNK2A1, DNMT1, DRD2, DYRK1A, ESR1, FABP4, GRM3, GRM8, HTR1B, HTR1E, HTR2B, IGF1R, MET, MMP12, MMP9, NR3C1, PIK3CA, PPARA, PRKCA, PTGS2, PTPN1, RORC, SRC, TERT, XDH | 3.67069 |
| [BP] GO:0033674 | positive regulation of kinase activity | CDC25B, DRD2, FLT3, GRM1, GRM5, HTR2A, HTR2B, KIT, PDE5A, PIK3CA, PIK3CB, PTPN1, SRC | 3.67069 |
| [BP] GO:0016310 | phosphorylation | APP, AURKB, AXL, BCL2, CDC25B, CSNK2A1, DRD1, DYRK1A, FLT3, HTR2B, IGF1R, KDR, KIT, MET, PIK3CA, PIK3CB, PIM1, PRKCA, SRC | 3.67069 |
| [BP] GO:0051046 | None | ACHE, CNR1, CYP19A1, DRD2, GRIK5, HCAR2, HTR1A, HTR1B, HTR2A, HTR2B, HTR2C, MAOB, MMP12, PRKCA, SRC | 3.66751 |
| [BP] GO:0016477 | cell migration | AXL, CNR2, CYP1B1, DRD1, DRD2, FUT7, HTR2B, HTR6, KDR, KIT, MMP1, MMP12, MMP9, PIK3CA, PIK3CB, SRC | 3.6558 |
| [BP] GO:0098771 | inorganic ion homeostasis | APP, BCL2, CA12, CA2, CA7, DRD1, DRD2, ESR1, GRM1, GRM5, HTR2A, HTR2B, HTR2C, PIK3CB | 3.64533 |
| [BP] GO:0006694 | steroid biosynthetic process | AKR1B1, CYP19A1, CYP3A4, HSD11B1, HSD11B2, HSD17B1, HSD17B2 | 3.63779 |
| [BP] GO:0007166 | cell surface receptor signaling pathway | ADORA3, APP, AXL, BCL2, CA1, CSNK2A1, DRD2, F3, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, IGF1R, KDR, KIT, MET, MMP2, MMP9, PIK3CA, PIK3CB, PRKCA, PTPN1, SRC | 3.63121 |
| [BP] GO:0032268 | regulation of cellular protein metabolic process | ALOX15, APP, AR, BCL2, CDC25B, CSNK2A1, DNMT1, DRD1, DRD2, DYRK1A, ESR1, F3, FABP4, FLT3, GRM1, GRM5, HTR2A, HTR2B, HTR2C, IGF1R, KDR, KIT, MMP9, PDE5A, PIK3CA, PIK3CB, PRKCA, PTGS2, PTPN1, SRC, XDH | 3.62503 |
| [BP] GO:0030803 | None | DRD2, GRM3, GRM8, HTR1B, PRKCA | 3.62083 |
| [BP] GO:0097164 | None | ACHE, AKR1B1, AKR1B10, CSNK2A1, DRD1, DRD2, HTR1A, MAOB | 3.60732 |
| [BP] GO:0043549 | regulation of kinase activity | APP, CDC25B, DRD2, FABP4, FLT3, GRM1, GRM5, HTR2A, HTR2B, IGF1R, KIT, PDE5A, PIK3CA, PIK3CB, PTPN1, SRC | 3.57673 |
| [BP] GO:0055074 | calcium ion homeostasis | APP, BCL2, DRD1, DRD2, ESR1, GRM1, GRM5, HTR2A, HTR2B, HTR2C, PIK3CB | 3.56874 |
| [BP] GO:0071417 | cellular response to organonitrogen compound | AKR1B1, APEX1, APP, DNMT1, DRD1, GRM5, HTR1B, IGF1R, MMP2, PTGS2, SRC | 3.54927 |
| [BP] GO:0018108 | peptidyl-tyrosine phosphorylation | AXL, DYRK1A, FLT3, IGF1R, KDR, KIT, MET, SRC | 3.54377 |
| [BP] GO:0030003 | cellular cation homeostasis | APP, BCL2, CA2, CA7, DRD1, DRD2, ESR1, GRM1, GRM5, HTR2A, HTR2B, HTR2C, PIK3CB | 3.53459 |
| [BP] GO:1904707 | positive regulation of vascular smooth muscle cell proliferation | HTR1B, MMP2, MMP9, TERT | 3.53423 |
| [BP] GO:0072503 | cellular divalent inorganic cation homeostasis | APP, BCL2, DRD1, DRD2, ESR1, GRM1, GRM5, HTR2A, HTR2B, HTR2C, PIK3CB | 3.52595 |
| [BP] GO:0048513 | animal organ development | ACHE, AR, AXL, BCL2, CA2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, ESR1, FLT3, HSD11B1, HSD17B2, KDR, KIT, PIK3CA, PPARA, SRC, TYR | 3.51889 |
| [BP] GO:0014062 | None | HTR1A, HTR1B, MAOB | 3.51257 |
| [BP] GO:0010511 | None | HTR2A, HTR2B, HTR2C | 3.51257 |
| [BP] GO:0042391 | None | APP, BCL2, CNR1, CNR2, DRD1, GRIA2, GRIA4, GRIK5, GRM5, KDR, SRC | 3.51154 |
| [BP] GO:0018212 | peptidyl-tyrosine modification | AXL, DYRK1A, FLT3, IGF1R, KDR, KIT, MET, SRC | 3.51143 |
| [BP] GO:1900372 | None | DRD2, GRM3, GRM8, HTR1B, PRKCA | 3.51143 |
| [BP] GO:0030809 | None | DRD2, GRM3, GRM8, HTR1B, PRKCA | 3.51143 |
| [BP] GO:0001505 | regulation of neurotransmitter levels | ACHE, CYP1B1, DRD1, DRD2, GRIK5, HTR1A, MAOB, PTGS2, SLC1A1 | 3.48236 |
| [BP] GO:0050801 | ion homeostasis | APP, BCL2, CA12, CA2, CA7, DRD1, DRD2, ESR1, GRM1, GRM5, HTR2A, HTR2B, HTR2C, PIK3CB | 3.47946 |
| [BP] GO:0048856 | anatomical structure development | ACHE, AKR1B1, ALOX15, ALPL, APP, AR, AXL, BCL2, CA2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DYRK1A, ESR1, FLT3, HSD11B1, HSD17B2, HTR5A, KDR, KIT, MAOB, MMP9, PGR, PIK3CA, PIM1, PPARA, PTGS2, RORC, SRC, TYR | 3.45284 |
| [BP] GO:0006873 | cellular ion homeostasis | APP, BCL2, CA2, CA7, DRD1, DRD2, ESR1, GRM1, GRM5, HTR2A, HTR2B, HTR2C, PIK3CB | 3.44629 |
| [BP] GO:2001023 | None | CNR1, DRD1, DRD2, HTR1B, HTR2A, MET | 3.44058 |
| [BP] GO:0001666 | response to hypoxia | BCL2, CYP1A1, DRD2, HSD11B2, MMP2, PPARA, PTGS2, SRC, TERT | 3.43683 |
| [BP] GO:0008210 | estrogen metabolic process | CYP19A1, CYP1B1, HSD17B1, HSD17B2 | 3.40807 |
| [BP] GO:1903409 | reactive oxygen species biosynthetic process | CYP1A1, CYP1A2, CYP1B1, MAOB | 3.40807 |
| [BP] GO:0051384 | response to glucocorticoid | ALPL, BCL2, FLT3, HSD11B2, MAOB, NR3C1, PTGS2 | 3.40699 |
| [BP] GO:0051347 | positive regulation of transferase activity | AURKB, CDC25B, DRD2, FLT3, GRM1, GRM5, HTR2A, HTR2B, KIT, PDE5A, PIK3CA, PIK3CB, PTPN1, SRC | 3.37841 |
| [BP] GO:0043406 | positive regulation of MAP kinase activity | FLT3, GRM1, HTR2A, HTR2B, KIT, PDE5A, PIK3CB, PTPN1, SRC | 3.37841 |
| [BP] GO:0080134 | regulation of response to stress | ABCB1, APP, CNR1, CNR2, CYP19A1, DRD2, DYRK1A, ESR1, F3, FABP4, IGF1R, MET, MMP12, MMP2, PPARA, PRKCA, PTGS2, PTPN1, SRC, TERT, XDH | 3.36373 |
| [BP] GO:0072507 | divalent inorganic cation homeostasis | APP, BCL2, DRD1, DRD2, ESR1, GRM1, GRM5, HTR2A, HTR2B, HTR2C, PIK3CB | 3.36179 |
| [BP] GO:0015711 | organic anion transport | ABCB1, CA1, CA12, CA14, CA2, CA4, CA7, CA9, DRD2, PPARA, SLC1A1 | 3.36179 |
| [BP] GO:0043405 | regulation of MAP kinase activity | FLT3, GRM1, HTR2A, HTR2B, IGF1R, KIT, PDE5A, PIK3CB, PTPN1, SRC | 3.34874 |
| [BP] GO:0050665 | hydrogen peroxide biosynthetic process | CYP1A1, CYP1A2, MAOB | 3.34874 |
| [BP] GO:0036293 | response to decreased oxygen levels | BCL2, CYP1A1, DRD2, HSD11B2, MMP2, PPARA, PTGS2, SRC, TERT | 3.34874 |
| [BP] GO:0048169 | None | APP, DRD2, GRM5, KIT | 3.34874 |
| [BP] GO:0006979 | response to oxidative stress | AKR1B1, APEX1, APP, AXL, BCL2, CYP1B1, MMP9, PTGS1, PTGS2, SRC | 3.31995 |
| [BP] GO:1901564 | organonitrogen compound metabolic process | ACHE, AKR1B1, ALPI, ALPL, APP, AR, AURKB, AXL, BACE1, BCL2, CDC25B, CSNK2A1, CYP1A1, CYP1A2, CYP3A4, DRD1, DRD2, DYRK1A, ESR1, F3, FLT3, FUT7, GLO1, HTR1A, HTR2B, HTR2C, IGF1R, KDR, KIT, MAOB, MET, MMP1, MMP12, MMP2, MMP9, PDE5A, PIK3CA, PIM1, PPARA, PRKCA, PTGS2, PTPN1, SRC, TOP2A, TYR, XDH | 3.29448 |
| [BP] GO:0043393 | regulation of protein binding | APP, AURKB, BCL2, MET, MMP9, PPARA, SRC, TERT | 3.28888 |
| [BP] GO:0035235 | None | APP, GRIA2, GRIA4, GRIK5 | 3.28501 |
| [BP] GO:1901699 | cellular response to nitrogen compound | AKR1B1, APEX1, APP, DNMT1, DRD1, GRM5, HTR1B, IGF1R, MMP2, PTGS2, SRC | 3.27941 |
| [BP] GO:0051338 | regulation of transferase activity | APP, AURKB, CDC25B, DRD2, FABP4, FLT3, GRM1, GRM5, HTR2A, HTR2B, IGF1R, KIT, PDE5A, PIK3CA, PIK3CB, PTPN1, SRC | 3.27941 |
| [BP] GO:0008217 | None | AR, CNR1, DRD2, HSD11B2, PPARA, PTGS1, PTGS2 | 3.23433 |
| [BP] GO:0032496 | response to lipopolysaccharide | ALPL, AXL, CNR1, CNR2, CYP1A1, CYP1A2, MAOB, PTGS2, SRC | 3.23433 |
| [BP] GO:0040011 | locomotion | AXL, CNR2, CYP1B1, DRD1, DRD2, FUT7, HTR2B, HTR6, KDR, KIT, MET, MMP1, MMP12, MMP9, PIK3CA, PIK3CB, SRC | 3.23433 |
| [BP] GO:0030817 | None | DRD1, DRD2, GRM3, GRM8, HTR1B, PRKCA | 3.23433 |
| [BP] GO:0048870 | cell motility | AXL, CNR2, CYP1B1, DRD1, DRD2, FUT7, HTR2B, HTR6, KDR, KIT, MMP1, MMP12, MMP9, PIK3CA, PIK3CB, SRC | 3.22204 |
| [BP] GO:0071073 | None | HTR2A, HTR2B, HTR2C | 3.20016 |
| [BP] GO:0051094 | positive regulation of developmental process | APP, AR, AXL, BCL2, CA2, CNR1, CYP1B1, DRD2, F3, HTR2A, HTR2C, KDR, KIT, PDE5A, PIM1, PRKCA, PTGS2, SRC, TERT | 3.20016 |
| [BP] GO:0001676 | long-chain fatty acid metabolic process | ALOX15, CYP1A1, CYP1A2, CYP1B1, PTGS1, PTGS2 | 3.19476 |
| [BP] GO:0051897 | positive regulation of protein kinase B signaling | AXL, F3, KIT, MET, PIK3CA, PIK3CB, SRC | 3.19303 |
| [BP] GO:0014059 | None | CNR1, DRD2, HTR1B, HTR2A | 3.17394 |
| [BP] GO:1901568 | fatty acid derivative metabolic process | ALOX15, ALOX5, CYP1A1, CYP1A2, CYP1B1, PTGS1, PTGS2 | 3.14027 |
| [BP] GO:0055080 | cation homeostasis | APP, BCL2, CA2, CA7, DRD1, DRD2, ESR1, GRM1, GRM5, HTR2A, HTR2B, HTR2C, PIK3CB | 3.13073 |
| [BP] GO:0010648 | negative regulation of cell communication | ACHE, AR, BCL2, CNR2, DRD1, DRD2, DYRK1A, ESR1, HTR1B, HTR2A, IGF1R, MET, MMP12, MMP9, PTGS2, PTPN1, SRC, TERT, XDH | 3.10831 |
| [BP] GO:0048015 | phosphatidylinositol-mediated signaling | HTR2A, HTR2B, IGF1R, PIK3CA, PIK3CB | 3.10356 |
| [BP] GO:0023057 | negative regulation of signaling | ACHE, AR, BCL2, CNR2, DRD1, DRD2, DYRK1A, ESR1, HTR1B, HTR2A, IGF1R, MET, MMP12, MMP9, PTGS2, PTPN1, SRC, TERT, XDH | 3.09193 |
| [BP] GO:0070482 | response to oxygen levels | BCL2, CYP1A1, DRD2, HSD11B2, MMP2, PPARA, PTGS2, SRC, TERT | 3.08794 |
| [BP] GO:0097267 | omega-hydroxylase P450 pathway | CYP1A1, CYP1A2, CYP1B1 | 3.06525 |
| [BP] GO:0035265 | organ growth | AR, BCL2, CYP19A1, ESR1 | 3.06525 |
| [BP] GO:0002209 | None | BCL2, DRD1, HTR1A, HTR2C | 3.06525 |
| [BP] GO:0001662 | None | BCL2, DRD1, HTR1A, HTR2C | 3.06525 |
| [BP] GO:0006367 | transcription initiation from RNA polymerase II promoter | AR, ESR1, NR3C1, NR3C2, PGR, PPARA, RORC | 3.06504 |
| [BP] GO:0043085 | positive regulation of catalytic activity | APP, AURKB, BCL2, CDC25B, DRD2, ESR1, F3, FLT3, GRM1, GRM5, HTR2A, HTR2B, KIT, PDE5A, PIK3CA, PIK3CB, PTPN1, SRC, TERT, XDH | 3.04623 |
| [BP] GO:0002237 | response to molecule of bacterial origin | ALPL, AXL, CNR1, CNR2, CYP1A1, CYP1A2, MAOB, PTGS2, SRC | 3.03826 |
| [BP] GO:0048609 | multicellular organismal reproductive process | AKR1B1, APP, AR, AXL, CNR1, CYP1A1, DRD1, ESR1, KIT, PGR, PTGS2, SRC | 3.02924 |
| [BP] GO:0042542 | response to hydrogen peroxide | AKR1B1, APEX1, AXL, BCL2, CYP1B1, SRC | 3.02924 |
| [BP] GO:0034614 | cellular response to reactive oxygen species | AKR1B1, APEX1, AXL, CYP1B1, MMP9, SRC | 3.02924 |
| [BP] GO:0048017 | inositol lipid-mediated signaling | HTR2A, HTR2B, IGF1R, PIK3CA, PIK3CB | 3.01911 |
| [BP] GO:0051246 | regulation of protein metabolic process | ALOX15, APP, AR, BCL2, CDC25B, CSNK2A1, DNMT1, DRD1, DRD2, DYRK1A, ESR1, F3, FABP4, FLT3, GRM1, GRM5, HTR2A, HTR2B, HTR2C, IGF1R, KDR, KIT, MMP9, PDE5A, PIK3CA, PIK3CB, PRKCA, PTGS2, PTPN1, SRC, XDH | 3.0155 |
| [BP] GO:0071704 | organic substance metabolic process | ACHE, AKR1B1, AKR1B10, ALOX15, ALOX5, ALPI, ALPL, APEX1, APP, AR, AURKB, AXL, BACE1, BCL2, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DNMT1, DRD1, DRD2, DYRK1A, ESR1, F3, FABP4, FLT3, FUT7, GLO1, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HTR1A, HTR1B, HTR2B, HTR2C, IGF1R, KDR, KIT, MAOB, MET, MMP1, MMP12, MMP2, MMP9, NR3C1, NR3C2, PDE5A, PGR, PIK3CA, PIK3CB, PIM1, PPARA, PRKCA, PTGS1, PTGS2, PTPN1, RORC, SRC, TERT, TOP2A, TYR, XDH | 2.97328 |
| [BP] GO:0042596 | None | BCL2, DRD1, HTR1A, HTR2C | 2.96702 |
| [BP] GO:0007568 | aging | APEX1, AURKB, BCL2, CNR1, CYP1A1, HTR2A, PTGS2, TERT | 2.96702 |
| [BP] GO:0002031 | None | DRD2, HTR1B, HTR2B | 2.95071 |
| [BP] GO:0002320 | lymphoid progenitor cell differentiation | BCL2, FLT3, KIT | 2.95071 |
| [BP] GO:0060736 | prostate gland growth | AR, CYP19A1, ESR1 | 2.95071 |
| [BP] GO:0006950 | response to stress | ACHE, ADORA3, AKR1B1, ALOX15, APEX1, APP, AXL, BCL2, CA2, CA9, CNR2, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, HSD11B2, HTR1A, HTR2C, KIT, MMP2, MMP9, PIK3CA, PIK3CB, PPARA, PTGS1, PTGS2, PTPN1, SRC, TERT, TOP2A | 2.94608 |
| [BP] GO:0007611 | None | APP, CNR1, DRD1, DRD2, GRM5, HTR2A, KIT, PTGS2 | 2.92271 |
| [BP] GO:0010863 | positive regulation of phospholipase C activity | ESR1, HTR2A, HTR2B, KIT | 2.92271 |
| [BP] GO:0000302 | response to reactive oxygen species | AKR1B1, APEX1, AXL, BCL2, CYP1B1, MMP9, SRC | 2.8559 |
| [BP] GO:0007167 | enzyme linked receptor protein signaling pathway | AXL, FLT3, IGF1R, KDR, KIT, MET, MMP2, MMP9, PIK3CA, PIK3CB, PRKCA, PTPN1, SRC | 2.84887 |
| [BP] GO:0007208 | None | HTR2A, HTR2C | 2.8472 |
| [BP] GO:1904018 | positive regulation of vasculature development | CYP1B1, F3, KDR, KIT, PRKCA, PTGS2, TERT | 2.8472 |
| [BP] GO:0006875 | cellular metal ion homeostasis | APP, BCL2, DRD1, DRD2, ESR1, GRM1, GRM5, HTR2A, HTR2B, HTR2C, PIK3CB | 2.84573 |
| [BP] GO:0048871 | multicellular organismal homeostasis | AKR1B1, DRD1, DRD2, HTR2A, MET, PIK3CA | 2.83873 |
| [BP] GO:0021885 | forebrain cell migration | AXL, DRD1, DRD2, HTR6 | 2.83105 |
| [BP] GO:0030802 | None | DRD1, DRD2, GRM3, GRM8, HTR1B, PRKCA | 2.82154 |
| [BP] GO:0032101 | regulation of response to external stimulus | CNR1, CNR2, CYP19A1, DRD1, DRD2, ESR1, F3, FABP4, KDR, MET, MMP12, PPARA, PRKCA, PTGS2 | 2.81858 |
| [BP] GO:1901654 | None | AKR1B1, AR, CA9, CSNK2A1, MAOB, NR3C1, SRC | 2.80933 |
| [BP] GO:0048585 | negative regulation of response to stimulus | ALOX15, AR, BCL2, CNR1, CNR2, CYP19A1, DRD1, DRD2, DYRK1A, ESR1, IGF1R, MET, MMP12, MMP9, PPARA, PTGS2, PTPN1, SRC, TERT, XDH | 2.8089 |
| [BP] GO:0048010 | vascular endothelial growth factor receptor signaling pathway | AXL, KDR, PIK3CA, PIK3CB, SRC | 2.8056 |
| [BP] GO:0009611 | response to wounding | ACHE, ADORA3, ALOX15, BCL2, CYP1A1, DRD2, PPARA | 2.79911 |
| [BP] GO:0051239 | regulation of multicellular organismal process | ADORA3, APP, AR, AXL, BCL2, CA2, CNR1, CYP1B1, DRD2, ESR1, F3, GRM1, HCAR2, HTR2A, HTR2B, HTR2C, KDR, KIT, MET, MMP12, MMP9, PDE5A, PIK3CA, PIM1, PRKCA, PTGS2, SLC1A1, SRC, TERT, XDH | 2.79911 |
| [BP] GO:0046486 | glycerolipid metabolic process | ACHE, ALOX15, ALPI, CSNK2A1, DRD2, FABP4, KIT, MET, PIK3CA, PIK3CB | 2.79911 |
| [BP] GO:0045597 | positive regulation of cell differentiation | APP, AR, AXL, BCL2, CA2, CNR1, DRD2, HTR2A, HTR2C, KDR, KIT, PDE5A, PRKCA, PTGS2, TERT | 2.7987 |
| [BP] GO:1900274 | regulation of phospholipase C activity | ESR1, HTR2A, HTR2B, KIT | 2.79567 |
| [BP] GO:0050806 | positive regulation of synaptic transmission | APP, CA2, CA7, DRD1, DRD2, PTGS2 | 2.79349 |
| [BP] GO:0046456 | icosanoid biosynthetic process | ALOX15, ALOX5, PTGS1, PTGS2 | 2.74992 |
| [BP] GO:0006703 | estrogen biosynthetic process | CYP19A1, HSD17B1, HSD17B2 | 2.74966 |
| [BP] GO:0006928 | movement of cell or subcellular component | APP, AXL, CNR2, CYP1B1, DRD1, DRD2, FUT7, HTR2B, HTR6, KDR, KIT, MMP1, MMP12, MMP9, PIK3CA, PIK3CB, PRKCA, PTGS2, SRC | 2.7224 |
| [BP] GO:0010634 | positive regulation of epithelial cell migration | KDR, MET, MMP9, PRKCA, PTGS2, SRC | 2.71834 |
| [BP] GO:0003006 | developmental process involved in reproduction | ALPL, AR, AXL, BCL2, CDC25B, CYP19A1, ESR1, HSD17B2, KIT, PGR, PTGS2, SRC | 2.71228 |
| [BP] GO:0051952 | None | CNR1, DRD1, DRD2, HTR1B, HTR2A | 2.70657 |
| [BP] GO:0022602 | ovulation cycle process | BCL2, ESR1, KIT, PGR, SRC | 2.70657 |
| [BP] GO:1904705 | regulation of vascular smooth muscle cell proliferation | HTR1B, MMP2, MMP9, TERT | 2.66715 |
| [BP] GO:0048660 | regulation of smooth muscle cell proliferation | AKR1B1, HTR1B, MMP2, MMP9, PTGS2, TERT | 2.66715 |
| [BP] GO:0006650 | glycerophospholipid metabolic process | ACHE, ALOX15, ALPI, CSNK2A1, DRD2, KIT, MET, PIK3CA, PIK3CB | 2.66715 |
| [BP] GO:0043065 | positive regulation of apoptotic process | BCL2, CNR1, CYP1B1, F3, GRIK5, HCAR2, MMP9, PIK3CB, PTGS2, SRC, TOP2A, XDH | 2.66435 |
| [BP] GO:0035556 | intracellular signal transduction | AKR1B1, AXL, BCL2, CYP1B1, DNMT1, DRD1, DRD2, GRM5, HTR2A, HTR2B, HTR5A, IGF1R, KDR, KIT, MET, PIK3CA, PIK3CB, PRKCA, PTPN1, SRC | 2.66364 |
| [BP] GO:0002682 | regulation of immune system process | ALOX15, APP, AXL, BCL2, CA2, CNR1, CNR2, CYP19A1, DRD2, ESR1, HCAR2, KIT, MMP12, MMP2, PDE5A, PIK3CA, PIK3CB, PRKCA, PTPN1, SRC | 2.66319 |
| [BP] GO:0060065 | uterus development | CYP19A1, ESR1, SRC | 2.66319 |
| [BP] GO:0051967 | None | DRD2, HTR1B, HTR2A | 2.66319 |
| [BP] GO:0030518 | intracellular steroid hormone receptor signaling pathway | AR, ESR1, NR3C1, PGR, SRC | 2.66319 |
| [BP] GO:1900371 | None | DRD1, DRD2, GRM3, GRM8, HTR1B, PRKCA | 2.65712 |
| [BP] GO:0002521 | leukocyte differentiation | AXL, BCL2, FLT3, FUT7, GLO1, KIT, MMP9, RORC | 2.64713 |
| [BP] GO:0030808 | None | DRD1, DRD2, GRM3, GRM8, HTR1B, PRKCA | 2.64049 |
| [BP] GO:1902532 | negative regulation of intracellular signal transduction | BCL2, DRD2, DYRK1A, ESR1, IGF1R, MET, MMP9, PTGS2, PTPN1, SRC, XDH | 2.63524 |
| [BP] GO:0044238 | primary metabolic process | ACHE, AKR1B1, AKR1B10, ALOX15, ALOX5, ALPI, ALPL, APEX1, APP, AR, AURKB, AXL, BACE1, BCL2, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DNMT1, DRD1, DRD2, DYRK1A, ESR1, F3, FABP4, FLT3, FUT7, GLO1, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HTR2B, HTR2C, IGF1R, KDR, KIT, MET, MMP1, MMP12, MMP2, MMP9, NR3C1, NR3C2, PDE5A, PGR, PIK3CA, PIK3CB, PIM1, PPARA, PRKCA, PTGS1, PTGS2, PTPN1, RORC, SRC, TERT, TOP2A, TYR, XDH | 2.63524 |
| [BP] GO:0043068 | positive regulation of programmed cell death | BCL2, CNR1, CYP1B1, F3, GRIK5, HCAR2, MMP9, PIK3CB, PTGS2, SRC, TOP2A, XDH | 2.63524 |
| [BP] GO:0046883 | regulation of hormone secretion | CNR1, CYP19A1, DRD2, HCAR2, HTR1A, HTR2A, HTR2C, PRKCA | 2.62917 |
| [BP] GO:0044057 | None | ADORA3, DRD2, GRM1, HCAR2, HTR2A, HTR2C, KIT, PDE5A, PRKCA, PTGS2, SLC1A1 | 2.62328 |
| [BP] GO:0003012 | None | DRD1, DRD2, HTR1D, HTR2A, HTR2B, HTR7, PDE5A, PIK3CA | 2.61969 |
| [BP] GO:0051130 | positive regulation of cellular component organization | ALOX15, APP, AR, AURKB, AXL, BCL2, CNR1, DNMT1, DRD2, ESR1, IGF1R, KDR, KIT, MET, MMP1, MMP9, SRC | 2.59934 |
| [BP] GO:0006811 | None | ABCB1, CA1, CA12, CA14, CA2, CA4, CA7, CA9, DRD1, DRD2, GRIA2, GRIA4, GRIK5, HTR2A, HTR2B, HTR2C, PPARA, SLC1A1 | 2.56248 |
| [BP] GO:1901652 | response to peptide | AKR1B1, APEX1, APP, GRM5, HSD11B2, IGF1R, PPARA, PTGS2, SRC | 2.56143 |
| [BP] GO:0048608 | reproductive structure development | AR, AXL, BCL2, CYP19A1, ESR1, HSD17B2, KIT, SRC | 2.55728 |
| [BP] GO:0045934 | None | APEX1, AR, AURKB, DNMT1, DRD2, DYRK1A, ESR1, FABP4, GRM3, GRM8, HTR1B, HTR1E, MMP12, NR3C1, PPARA, PRKCA, RORC, SRC, TERT | 2.55728 |
| [BP] GO:0071902 | positive regulation of protein serine/threonine kinase activity | FLT3, GRM1, HTR2A, HTR2B, KIT, PDE5A, PIK3CB, PTPN1, SRC | 2.54592 |
| [BP] GO:0007612 | None | APP, DRD1, DRD2, GRM5, KIT, PTGS2 | 2.54592 |
| [BP] GO:0050890 | None | APP, CNR1, DRD1, DRD2, GRM5, HTR2A, KIT, PTGS2 | 2.53798 |
| [BP] GO:1901989 | None | APEX1, APP, CDC25B, CYP1A1, TERT | 2.52886 |
| [BP] GO:0006584 | None | AKR1B1, DRD1, DRD2, MAOB | 2.52886 |
| [BP] GO:0009712 | None | AKR1B1, DRD1, DRD2, MAOB | 2.52886 |
| [BP] GO:2000811 | negative regulation of anoikis | BCL2, PIK3CA, SRC | 2.50728 |
| [BP] GO:0071071 | None | HTR2A, HTR2B, HTR2C | 2.50728 |
| [BP] GO:0030540 | female genitalia development | AXL, CYP19A1, ESR1 | 2.50728 |
| [BP] GO:0032225 | None | DRD1, DRD2, PTGS2 | 2.50728 |
| [BP] GO:0019372 | lipoxygenase pathway | ALOX15, ALOX5, PTGS2 | 2.50728 |
| [BP] GO:0050999 | None | CNR1, CNR2, HTR2B, TERT | 2.49535 |
| [BP] GO:0051050 | positive regulation of transport | ABCB1, ACHE, APP, AXL, BCL2, CA2, CYP19A1, DRD1, DRD2, HCAR2, HTR2B, MMP12, PTGS2, SRC, TERT | 2.48779 |
| [BP] GO:0006352 | DNA-templated transcription, initiation | AR, ESR1, NR3C1, NR3C2, PGR, PPARA, RORC | 2.47883 |
| [BP] GO:0051283 | None | DRD2, HTR2A, HTR2B, HTR2C | 2.46066 |
| [BP] GO:0051209 | None | DRD2, HTR2A, HTR2B, HTR2C | 2.46066 |
| [BP] GO:0006820 | anion transport | ABCB1, CA1, CA12, CA14, CA2, CA4, CA7, CA9, DRD2, PPARA, SLC1A1 | 2.45982 |
| [BP] GO:0055065 | metal ion homeostasis | APP, BCL2, DRD1, DRD2, ESR1, GRM1, GRM5, HTR2A, HTR2B, HTR2C, PIK3CB | 2.45982 |
| [BP] GO:0099566 | None | GRM1, GRM5 | 2.45399 |
| [BP] GO:0060748 | None | AR, PGR | 2.45399 |
| [BP] GO:0032849 | positive regulation of cellular pH reduction | CA2, CA7 | 2.45399 |
| [BP] GO:0033602 | None | CNR1, DRD2 | 2.45399 |
| [BP] GO:0045931 | positive regulation of mitotic cell cycle | APEX1, APP, CDC25B, CYP1A1, PRKCA, TERT | 2.43553 |
| [BP] GO:0032845 | None | BCL2, DRD2, HTR2A, HTR2B, HTR2C, SRC | 2.43553 |
| [BP] GO:0051480 | regulation of cytosolic calcium ion concentration | DRD1, DRD2, ESR1, GRM1, GRM5, HTR2A, HTR2B, HTR2C | 2.42473 |
| [BP] GO:0009416 | response to light stimulus | APP, AURKB, BCL2, DRD1, DRD2, KIT, PTGS2, TYR | 2.42473 |
| [BP] GO:2001234 | negative regulation of apoptotic signaling pathway | AR, BCL2, MMP9, PTGS2, PTPN1, SRC, TERT | 2.41827 |
| [BP] GO:0090066 | None | ALOX15, DRD1, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR7, PTGS2 | 2.41165 |
| [BP] GO:0009410 | None | CNR1, CNR2, DRD1, DRD2, HTR1B, NR3C1 | 2.40752 |
| [BP] GO:0050433 | None | CNR1, DRD2, HTR1B, HTR2A | 2.40582 |
| [BP] GO:0045787 | positive regulation of cell cycle | APEX1, APP, AURKB, CDC25B, CYP1A1, DRD2, PRKCA, SRC, TERT | 2.39767 |
| [BP] GO:0006936 | None | DRD1, DRD2, HTR1D, HTR2A, HTR2B, HTR7, PIK3CA | 2.38575 |
| [BP] GO:0071248 | cellular response to metal ion | ALOX15, CYP1A1, CYP1A2, FABP4, MMP9, PTGS2 | 2.37949 |
| [BP] GO:0060255 | regulation of macromolecule metabolic process | ACHE, ADORA3, ALOX15, APEX1, APP, AR, AURKB, BCL2, CA9, CDC25B, CSNK2A1, CYP1A2, CYP1B1, DNMT1, DRD1, DRD2, DYRK1A, ESR1, F3, FABP4, FLT3, GLO1, GRM1, GRM5, HTR2A, HTR2B, HTR2C, IGF1R, KDR, KIT, MET, MMP12, MMP9, NR3C1, NR3C2, PDE5A, PGR, PIK3CA, PIK3CB, PIM1, PPARA, PRKCA, PTGS2, PTPN1, RORC, SRC, TERT, TOP2A, XDH | 2.37629 |
| [BP] GO:0008542 | None | APP, DRD1, DRD2, KIT | 2.3748 |
| [BP] GO:0010942 | positive regulation of cell death | BCL2, CNR1, CYP1B1, F3, GRIK5, HCAR2, MMP9, PIK3CB, PTGS2, SRC, TOP2A, XDH | 2.3748 |
| [BP] GO:0008150 | biological_process | ABCB1, ACHE, ADORA3, AKR1B1, AKR1B10, ALOX15, ALOX5, ALPI, ALPL, APEX1, APP, AR, AURKB, AXL, BACE1, BCL2, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CDC25B, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DNMT1, DRD1, DRD2, DYRK1A, ESR1, F3, FABP4, FLT3, FUT7, GLO1, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IGF1R, KDR, KIT, MAOB, MET, MMP1, MMP12, MMP2, MMP9, NQO2, NR3C1, NR3C2, PDE5A, PGR, PIK3CA, PIK3CB, PIM1, PPARA, PRKCA, PTGS1, PTGS2, PTPN1, RORC, SLC1A1, SRC, TERT, TOP2A, TYR, XDH | 2.37441 |
| [BP] GO:0018193 | peptidyl-amino acid modification | AURKB, AXL, BCL2, CSNK2A1, DRD1, DYRK1A, FLT3, IGF1R, KDR, KIT, MET, PRKCA, SRC, TOP2A | 2.37441 |
| [BP] GO:0010518 | positive regulation of phospholipase activity | ESR1, HTR2A, HTR2B, KIT | 2.34397 |
| [BP] GO:0030100 | regulation of endocytosis | ALOX15, APP, AXL, DRD2, PIK3CB, PTPN1, SRC | 2.33178 |
| [BP] GO:0006631 | fatty acid metabolic process | ALOX15, ALOX5, CYP1A1, CYP1A2, CYP1B1, PPARA, PTGS1, PTGS2 | 2.32698 |
| [BP] GO:0019637 | organophosphate metabolic process | ACHE, ALOX15, ALPI, CSNK2A1, DRD2, HTR2B, HTR2C, KIT, MET, PDE5A, PIK3CA, PIK3CB, PTGS2, XDH | 2.32665 |
| [BP] GO:0007631 | None | APP, DRD1, DRD2, HTR1B, HTR2C | 2.32055 |
| [BP] GO:2001243 | negative regulation of intrinsic apoptotic signaling pathway | BCL2, MMP9, PTGS2, PTPN1, SRC | 2.32055 |
| [BP] GO:0042053 | None | DRD1, HTR1A, MAOB | 2.31815 |
| [BP] GO:0042069 | None | DRD1, HTR1A, MAOB | 2.31815 |
| [BP] GO:0051900 | regulation of mitochondrial depolarization | BCL2, KDR, SRC | 2.31815 |
| [BP] GO:0045766 | positive regulation of angiogenesis | CYP1B1, F3, KDR, PRKCA, PTGS2, TERT | 2.30243 |
| [BP] GO:0048167 | None | APP, DRD1, DRD2, GRM5, KIT, PTGS2 | 2.30243 |
| [BP] GO:0048168 | None | APP, DRD2, GRM5, KIT | 2.28873 |
| [BP] GO:0048869 | cellular developmental process | ACHE, ALPL, APP, AR, AXL, BCL2, CDC25B, CYP1A1, DRD1, DRD2, ESR1, FABP4, FLT3, FUT7, GLO1, HTR2B, KDR, KIT, MET, MMP2, MMP9, PGR, PTGS2, RORC, SRC, TERT, TOP2A | 2.26504 |
| [BP] GO:0048148 | None | DRD1, DRD2, HTR2A | 2.25562 |
| [BP] GO:0007632 | None | APP, DRD1, DRD2, KIT | 2.22774 |
| [BP] GO:0019233 | None | CNR1, CNR2, GRM1, PTGS2 | 2.22774 |
| [BP] GO:0032880 | regulation of protein localization | ACHE, APP, AR, BCL2, CNR1, CSNK2A1, DRD2, HCAR2, HTR2B, MMP12, PRKCA, PTGS2, PTPN1, SRC, TERT | 2.22386 |
| [BP] GO:0009891 | positive regulation of biosynthetic process | APP, AR, AURKB, DRD1, DRD2, ESR1, HTR2A, HTR2B, HTR2C, IGF1R, KDR, MET, MMP12, NR3C1, PGR, PPARA, PTGS2, RORC, SRC, TERT, TOP2A | 2.20843 |
| [BP] GO:0009894 | regulation of catabolic process | APEX1, BCL2, CNR1, CSNK2A1, HCAR2, HTR2A, HTR2B, KDR, MET, PIK3CA, PIK3CB, PPARA, PRKCA, PTPN1 | 2.20843 |
| [BP] GO:0050730 | None | APP, FLT3, GRM5, HTR2A, KIT, PTPN1, SRC | 2.20843 |
| [BP] GO:0033555 | multicellular organismal response to stress | BCL2, DRD1, HTR1A, HTR2C | 2.20616 |
| [BP] GO:0051172 | None | APEX1, APP, AR, AURKB, CSNK2A1, DNMT1, DRD2, DYRK1A, ESR1, FABP4, GRM3, GRM8, HTR1B, HTR1E, IGF1R, MMP12, MMP9, NR3C1, PPARA, PRKCA, PTGS2, PTPN1, RORC, SRC, TERT, XDH | 2.20616 |
| [BP] GO:0071498 | cellular response to fluid shear stress | CA2, PTGS2, SRC | 2.20616 |
| [BP] GO:0019373 | epoxygenase P450 pathway | CYP1A1, CYP1A2, CYP1B1 | 2.20616 |
| [BP] GO:0033031 | positive regulation of neutrophil apoptotic process | HCAR2, PIK3CB | 2.20616 |
| [BP] GO:0038171 | None | CNR1, CNR2 | 2.20616 |
| [BP] GO:0014063 | None | HTR1B, MAOB | 2.20616 |
| [BP] GO:0018894 | dibenzo-p-dioxin metabolic process | CYP1A1, CYP1A2 | 2.20616 |
| [BP] GO:0014827 | None | HTR1D, HTR2B | 2.20616 |
| [BP] GO:0022900 | electron transport chain | AKR1B1, CYP19A1, CYP1A2, MAOB, NQO2, XDH | 2.20556 |
| [BP] GO:0072593 | reactive oxygen species metabolic process | BCL2, CYP1A1, CYP1A2, CYP1B1, MAOB | 2.20556 |
| [BP] GO:0019219 | regulation of nucleobase-containing compound metabolic process | ADORA3, APEX1, APP, AR, AURKB, CA9, CSNK2A1, CYP1B1, DNMT1, DRD1, DRD2, DYRK1A, ESR1, FABP4, GLO1, GRM3, GRM8, HTR1B, HTR1E, HTR2A, IGF1R, KIT, MET, MMP12, NR3C1, NR3C2, PDE5A, PGR, PIK3CA, PIM1, PPARA, PRKCA, PTPN1, RORC, SRC, TERT, TOP2A | 2.20556 |
| [BP] GO:0045936 | None | DRD2, FABP4, GRM3, GRM8, HTR1B, HTR1E, IGF1R, PPARA, PRKCA, PTPN1, XDH | 2.20028 |
| [BP] GO:0010563 | None | DRD2, FABP4, GRM3, GRM8, HTR1B, HTR1E, IGF1R, PPARA, PRKCA, PTPN1, XDH | 2.19477 |
| [BP] GO:0031623 | None | ACHE, DRD2, HTR1B, HTR2B | 2.18716 |
| [BP] GO:0032768 | None | CNR1, CNR2, HTR2B, TERT | 2.18716 |
| [BP] GO:0090087 | None | ACHE, APP, CA2, CNR1, DRD2, HCAR2, HTR2B, HTR2C, MMP12, PRKCA, PTGS2, PTPN1, SRC | 2.17101 |
| [BP] GO:0018105 | peptidyl-serine phosphorylation | AURKB, BCL2, DRD1, DYRK1A, PRKCA, SRC | 2.16899 |
| [BP] GO:0046686 | response to cadmium ion | CYP1A2, KIT, MMP9, TERT | 2.1592 |
| [BP] GO:0007613 | None | CNR1, DRD1, DRD2, HTR2A, PTGS2 | 2.1543 |
| [BP] GO:0071900 | regulation of protein serine/threonine kinase activity | FLT3, GRM1, HTR2A, HTR2B, IGF1R, KIT, PDE5A, PIK3CB, PTPN1, SRC | 2.14053 |
| [BP] GO:0006644 | phospholipid metabolic process | ACHE, ALOX15, ALPI, CSNK2A1, DRD2, KIT, MET, PIK3CA, PIK3CB | 2.1344 |
| [BP] GO:0097553 | None | DRD2, HTR2A, HTR2B, HTR2C | 2.1344 |
| [BP] GO:0006721 | terpenoid metabolic process | AKR1B10, CYP1A1, CYP1A2, CYP1B1, CYP3A4 | 2.12102 |
| [BP] GO:2000209 | regulation of anoikis | BCL2, PIK3CA, SRC | 2.10352 |
| [BP] GO:0009404 | toxin metabolic process | CYP1A1, CYP1A2, CYP1B1 | 2.10352 |
| [BP] GO:0071241 | cellular response to inorganic substance | ALOX15, CYP1A1, CYP1A2, FABP4, MMP9, PTGS2 | 2.08122 |
| [BP] GO:0010517 | regulation of phospholipase activity | ESR1, HTR2A, HTR2B, KIT | 2.08122 |
| [BP] GO:0070988 | demethylation | APEX1, CYP1A1, CYP1A2, CYP3A4 | 2.08122 |
| [BP] GO:0030168 | platelet activation | AXL, PIK3CA, PIK3CB, PRKCA, SRC | 2.07011 |
| [BP] GO:0050731 | positive regulation of peptidyl-tyrosine phosphorylation | FLT3, GRM5, HTR2A, KIT, PTPN1, SRC | 2.07011 |
| [BP] GO:0050678 | None | AR, F3, HTR2B, KDR, MMP12, PGR, PRKCA, XDH | 2.0571 |
| [BP] GO:0007204 | positive regulation of cytosolic calcium ion concentration | DRD1, DRD2, ESR1, GRM1, HTR2A, HTR2B, HTR2C | 2.05384 |
| [BP] GO:0032098 | None | HTR2C, HTR4, PPARA | 2.05383 |
| [BP] GO:1901342 | regulation of vasculature development | CYP1B1, F3, KDR, KIT, PRKCA, PTGS2, TERT, XDH | 2.05072 |
| [BP] GO:0050679 | None | AR, F3, HTR2B, KDR, MMP12, PRKCA | 2.0473 |
| [BP] GO:0070301 | cellular response to hydrogen peroxide | AKR1B1, APEX1, AXL, CYP1B1 | 2.03175 |
| [BP] GO:0051282 | None | DRD1, DRD2, HTR2A, HTR2B, HTR2C | 2.02211 |
| [BP] GO:0021853 | None | DRD1, DRD2 | 2.0182 |
| [BP] GO:0010641 | None | F3, SRC | 2.0182 |
| [BP] GO:0071502 | None | HTR1B, HTR2B | 2.0182 |
| [BP] GO:0002318 | myeloid progenitor cell differentiation | FLT3, KIT | 2.0182 |
| [BP] GO:1904936 | None | DRD1, DRD2 | 2.0182 |
| [BP] GO:0060193 | positive regulation of lipase activity | ESR1, HTR2A, HTR2B, KIT | 2.01185 |
| [BP] GO:0001503 | ossification | ALOX15, ALPL, BCL2, MMP2, MMP9 | 2.01173 |
| [BP] GO:0007626 | None | APP, DRD1, DRD2, GRM1, GRM5, HTR2C | 2.00424 |
| [CC] GO:0005886 | plasma membrane | ABCB1, ACHE, ADORA3, ALOX15, ALPI, ALPL, APP, AR, AXL, BACE1, CA12, CA14, CA2, CA4, CA9, CNR1, CNR2, CSNK2A1, DRD1, DRD2, ESR1, F3, FLT3, GLO1, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IGF1R, KDR, KIT, MET, MMP2, PIK3CA, PIK3CB, PIM1, PRKCA, PTPN1, SLC1A1, SRC, TERT | 10.89 |
| [CC] GO:0016020 | membrane | ABCB1, ACHE, ADORA3, ALOX15, ALOX5, ALPI, ALPL, APP, AR, AXL, BACE1, BCL2, CA12, CA14, CA2, CA4, CA9, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD1, DRD2, ESR1, F3, FLT3, FUT7, GLO1, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, HSD11B1, HSD11B2, HSD17B2, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IGF1R, KDR, KIT, MAOB, MET, MMP2, NR3C2, PGR, PIK3CA, PIK3CB, PIM1, PRKCA, PTGS1, PTGS2, PTPN1, SLC1A1, SRC, TERT, TYR | 9.89258 |
| [CC] GO:0031226 | intrinsic component of plasma membrane | ADORA3, APP, AXL, BACE1, CA4, CNR1, CNR2, DRD1, DRD2, F3, FLT3, GRIA2, GRM1, GRM3, GRM5, GRM8, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, SLC1A1 | 9.36652 |
| [CC] GO:0044459 | plasma membrane part | ABCB1, ADORA3, ALOX15, APP, AXL, BACE1, CA2, CA4, CA9, CNR1, CNR2, DRD1, DRD2, F3, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IGF1R, KDR, KIT, MET, PTGS2, SLC1A1, SRC | 8.49622 |
| [CC] GO:0005887 | integral component of plasma membrane | ADORA3, APP, AXL, BACE1, CNR1, CNR2, DRD1, DRD2, FLT3, GRIA2, GRM1, GRM3, GRM5, GRM8, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, SLC1A1 | 8.39147 |
| [CC] GO:0044425 | membrane part | ABCB1, ACHE, ADORA3, ALOX15, ALPI, ALPL, APP, AXL, BACE1, BCL2, CA12, CA14, CA2, CA4, CA9, CNR1, CNR2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD1, DRD2, ESR1, F3, FLT3, FUT7, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, HSD11B1, HSD11B2, HSD17B2, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IGF1R, KDR, KIT, MAOB, MET, NR3C2, PIK3CA, PIK3CB, PTGS1, PTGS2, PTPN1, SLC1A1, SRC, TYR | 7.86181 |
| [CC] GO:0098590 | plasma membrane region | ABCB1, CA2, CA4, CA9, CNR1, DRD1, DRD2, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HTR2A, MET, PTGS2, SLC1A1, SRC | 4.59544 |
| [CC] GO:0043005 | None | APP, BACE1, CA2, CNR1, CNR2, DRD2, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, HTR2A, HTR2B, HTR5A, PTGS2, SRC | 4.53029 |
| [CC] GO:0042734 | None | CNR1, GRIK5, GRM1, GRM3, GRM5, GRM8 | 4.24186 |
| [CC] GO:0120025 | None | AKR1B1, APP, BACE1, CA2, CNR1, CNR2, DRD1, DRD2, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, HTR2A, HTR2B, HTR5A, HTR6, PIK3CA, PTGS2, SRC | 4.01284 |
| [CC] GO:0031224 | None | ABCB1, ACHE, ADORA3, ALPI, ALPL, APP, AXL, BACE1, CA12, CA14, CA4, CA9, CNR1, CNR2, CYP3A4, DRD1, DRD2, ESR1, F3, FLT3, FUT7, GRIA2, GRM1, GRM3, GRM5, GRM8, HCAR2, HSD11B1, HSD17B2, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IGF1R, KDR, KIT, MAOB, MET, SLC1A1, TYR | 3.76315 |
| [CC] GO:0042995 | cell projection | AKR1B1, APP, BACE1, CA2, CNR1, CNR2, DRD1, DRD2, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, HTR2A, HTR2B, HTR5A, HTR6, PIK3CA, PTGS2, SRC | 3.67069 |
| [CC] GO:0016021 | None | ABCB1, ADORA3, ALPI, ALPL, APP, AXL, BACE1, CA12, CA14, CA9, CNR1, CNR2, CYP3A4, DRD1, DRD2, ESR1, F3, FLT3, FUT7, GRIA2, GRM1, GRM3, GRM5, GRM8, HCAR2, HSD11B1, HSD17B2, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IGF1R, KDR, KIT, MAOB, MET, SLC1A1, TYR | 3.22197 |
| [CC] GO:0044464 | cell part | ABCB1, ACHE, ADORA3, AKR1B1, AKR1B10, ALOX15, ALOX5, ALPI, ALPL, APEX1, APP, AR, AURKB, AXL, BACE1, BCL2, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CDC25B, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DNMT1, DRD1, DRD2, DYRK1A, ESR1, F3, FABP4, FLT3, FUT7, GLO1, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IGF1R, KDR, KIT, MAOB, MET, MMP12, MMP2, MMP9, NQO2, NR3C1, NR3C2, PDE5A, PGR, PIK3CA, PIK3CB, PIM1, PPARA, PRKCA, PTGS1, PTGS2, PTPN1, RORC, SLC1A1, SRC, TERT, TOP2A, TYR, XDH | 2.94608 |
| [CC] GO:0097458 | None | APP, BACE1, CA2, CNR1, CNR2, DRD2, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HTR2A, HTR2B, HTR5A, PTGS1, PTGS2, SRC | 2.66435 |
| [CC] GO:0044432 | endoplasmic reticulum part | APP, BACE1, BCL2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD1, FLT3, GRIA2, HSD11B1, HSD11B2, HSD17B2, NR3C2, PTGS1, PTGS2, PTPN1 | 2.61257 |
| [CC] GO:0097060 | None | CNR1, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8 | 2.40752 |
| [CC] GO:0044456 | None | ACHE, APP, CNR1, DRD2, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, SRC | 2.20616 |
| [CC] GO:0005789 | endoplasmic reticulum membrane | BCL2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD1, GRIA2, HSD11B1, HSD11B2, HSD17B2, NR3C2, PTGS1, PTGS2 | 2.20426 |
| [MF] GO:0030594 | None | DRD1, DRD2, GRIA2, GRIA4, GRIK5, GRM1, GRM5, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7 | 17.9699 |
| [MF] GO:0004993 | None | HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7 | 15.8141 |
| [MF] GO:0099589 | None | HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7 | 15.8141 |
| [MF] GO:0043176 | None | HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR5A, HTR7 | 15.8141 |
| [MF] GO:0051378 | None | HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR5A, HTR7 | 15.8141 |
| [MF] GO:0038023 | signaling receptor activity | ADORA3, AR, AXL, CNR1, CNR2, DRD1, DRD2, ESR1, F3, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IGF1R, KDR, KIT, MET, NR3C1, NR3C2, PGR, PPARA, RORC | 15.6478 |
| [MF] GO:0046914 | transition metal ion binding | ALOX15, ALOX5, ALPI, APP, AR, CA1, CA12, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DNMT1, ESR1, GLO1, MMP1, MMP12, MMP2, MMP9, NQO2, NR3C1, NR3C2, PGR, PIM1, PPARA, PRKCA, PTPN1, RORC, TYR, XDH | 15.3399 |
| [MF] GO:0043167 | ion binding | ABCB1, ACHE, ALOX15, ALOX5, ALPI, ALPL, APEX1, APP, AR, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DNMT1, DRD1, DRD2, DYRK1A, ESR1, F3, FABP4, FLT3, GLO1, HSD17B1, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR5A, HTR7, IGF1R, KDR, KIT, MAOB, MET, MMP1, MMP12, MMP2, MMP9, NQO2, NR3C1, NR3C2, PDE5A, PGR, PIK3CA, PIK3CB, PIM1, PPARA, PRKCA, PTGS1, PTGS2, PTPN1, RORC, SLC1A1, SRC, TERT, TOP2A, TYR, XDH | 15.0618 |
| [MF] GO:0004872 | receptor activity | ADORA3, AR, AXL, CNR1, CNR2, DRD1, DRD2, ESR1, F3, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IGF1R, KDR, KIT, MET, NR3C1, NR3C2, PGR, PPARA, RORC | 14.0108 |
| [MF] GO:0060089 | molecular transducer activity | ADORA3, AR, AXL, CNR1, CNR2, DRD1, DRD2, ESR1, F3, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IGF1R, KDR, KIT, MET, NR3C1, NR3C2, PGR, PPARA, RORC | 13.611 |
| [MF] GO:0099528 | None | HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7 | 13.5357 |
| [MF] GO:0008227 | None | DRD2, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7 | 13.1899 |
| [MF] GO:0004871 | signal transducer activity | ADORA3, AR, AXL, CNR1, CNR2, DRD1, DRD2, ESR1, F3, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IGF1R, KDR, KIT, MET, NR3C1, NR3C2, PGR, PPARA, RORC | 12.7542 |
| [MF] GO:0043169 | cation binding | ACHE, ALOX15, ALOX5, ALPI, ALPL, APEX1, APP, AR, AURKB, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DNMT1, DRD1, DRD2, ESR1, GLO1, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR5A, HTR7, KIT, MMP1, MMP12, MMP2, MMP9, NQO2, NR3C1, NR3C2, PDE5A, PGR, PIM1, PPARA, PRKCA, PTGS1, PTGS2, PTPN1, RORC, SLC1A1, TERT, TOP2A, TYR, XDH | 12.3202 |
| [MF] GO:0070405 | ammonium ion binding | ACHE, DRD1, DRD2, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR5A, HTR7 | 11.9143 |
| [MF] GO:0099600 | transmembrane receptor activity | ADORA3, AXL, CNR1, CNR2, DRD1, DRD2, F3, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IGF1R, KDR, KIT, MET | 10.9617 |
| [MF] GO:0004888 | transmembrane signaling receptor activity | ADORA3, AXL, CNR1, CNR2, DRD1, DRD2, F3, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IGF1R, KDR, KIT, MET | 10.9617 |
| [MF] GO:0042165 | neurotransmitter binding | ACHE, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR5A, HTR7 | 10.3958 |
| [MF] GO:0004089 | carbonate dehydratase activity | CA1, CA12, CA14, CA2, CA4, CA7, CA9 | 9.75767 |
| [MF] GO:0008270 | zinc ion binding | ALPI, AR, CA1, CA12, CA2, CA4, CA7, CA9, DNMT1, ESR1, GLO1, MMP1, MMP12, MMP2, MMP9, NQO2, NR3C1, NR3C2, PGR, PPARA, PRKCA, PTPN1, RORC | 8.72394 |
| [MF] GO:0008066 | None | GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8 | 7.86882 |
| [MF] GO:0008144 | drug binding | ABCB1, ACHE, AURKB, AXL, CNR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD1, DRD2, DYRK1A, FLT3, HTR1B, HTR2A, HTR2B, HTR2C, IGF1R, KDR, KIT, MET, NQO2, PIK3CA, PIK3CB, PIM1, PPARA, PRKCA, SRC, TOP2A | 7.74115 |
| [MF] GO:0003824 | catalytic activity | ABCB1, ACHE, AKR1B1, AKR1B10, ALOX15, ALOX5, ALPI, ALPL, APEX1, AURKB, AXL, BACE1, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DNMT1, DYRK1A, F3, FLT3, FUT7, GLO1, HSD11B1, HSD11B2, HSD17B1, HSD17B2, IGF1R, KDR, KIT, MAOB, MET, MMP1, MMP12, MMP2, MMP9, NQO2, PDE5A, PIK3CA, PIK3CB, PIM1, PRKCA, PTGS1, PTGS2, PTPN1, SRC, TERT, TOP2A, TYR, XDH | 7.40265 |
| [MF] GO:0016491 | oxidoreductase activity | AKR1B1, AKR1B10, ALOX15, ALOX5, APEX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, HSD11B1, HSD11B2, HSD17B1, HSD17B2, MAOB, NQO2, PTGS1, PTGS2, TYR, XDH | 7.16713 |
| [MF] GO:0005496 | steroid binding | AR, CYP3A4, ESR1, HSD11B2, HSD17B1, NR3C1, NR3C2, PGR, RORC | 7.05259 |
| [MF] GO:0004930 | None | ADORA3, CNR1, CNR2, DRD1, DRD2, GRM1, GRM3, GRM5, GRM8, HCAR2, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7 | 6.66372 |
| [MF] GO:0016835 | carbon-oxygen lyase activity | APEX1, CA1, CA12, CA14, CA2, CA4, CA7, CA9 | 6.21837 |
| [MF] GO:0016836 | hydro-lyase activity | CA1, CA12, CA14, CA2, CA4, CA7, CA9 | 5.80459 |
| [MF] GO:0046872 | metal ion binding | ALOX15, ALOX5, ALPI, ALPL, APEX1, APP, AR, AURKB, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DNMT1, ESR1, GLO1, KIT, MMP1, MMP12, MMP2, MMP9, NQO2, NR3C1, NR3C2, PDE5A, PGR, PIM1, PPARA, PRKCA, PTGS1, PTGS2, PTPN1, RORC, SLC1A1, TERT, TOP2A, TYR, XDH | 5.6467 |
| [MF] GO:0003707 | steroid hormone receptor activity | AR, ESR1, NR3C1, NR3C2, PGR, PPARA, RORC | 5.62723 |
| [MF] GO:0070330 | aromatase activity | CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4 | 4.97721 |
| [MF] GO:0016712 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen | CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4 | 4.71758 |
| [MF] GO:0020037 | heme binding | CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, PTGS1, PTGS2, SRC | 4.59609 |
| [MF] GO:0016829 | lyase activity | APEX1, CA1, CA12, CA14, CA2, CA4, CA7, CA9, GLO1 | 4.49806 |
| [MF] GO:0097159 | organic cyclic compound binding | ABCB1, APEX1, APP, AR, AURKB, AXL, BCL2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DNMT1, DRD1, DRD2, DYRK1A, ESR1, FLT3, HSD11B2, HSD17B1, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR5A, HTR7, IGF1R, KDR, KIT, MAOB, MET, MMP12, NQO2, NR3C1, NR3C2, PDE5A, PGR, PIK3CA, PIK3CB, PIM1, PPARA, PRKCA, PTGS1, PTGS2, PTPN1, RORC, SRC, TERT, TOP2A, XDH | 4.46384 |
| [MF] GO:0046906 | tetrapyrrole binding | CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, PTGS1, PTGS2, SRC | 4.39349 |
| [MF] GO:0004714 | transmembrane receptor protein tyrosine kinase activity | AXL, FLT3, IGF1R, KDR, KIT, MET | 4.24186 |
| [MF] GO:0048037 | cofactor binding | CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, HSD11B2, HSD17B1, MAOB, NQO2, PTGS1, PTGS2, SRC, XDH | 4.21409 |
| [MF] GO:0016705 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen | CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, PTGS1, PTGS2, TYR | 4.06271 |
| [MF] GO:0005506 | iron ion binding | ALOX15, ALOX5, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, XDH | 3.96616 |
| [MF] GO:1901363 | heterocyclic compound binding | ABCB1, APEX1, APP, AR, AURKB, AXL, BCL2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DNMT1, DYRK1A, ESR1, FLT3, HSD11B2, HSD17B1, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR5A, HTR7, IGF1R, KDR, KIT, MAOB, MET, MMP12, NQO2, NR3C1, NR3C2, PDE5A, PGR, PIK3CA, PIK3CB, PIM1, PPARA, PRKCA, PTGS1, PTGS2, PTPN1, RORC, SRC, TERT, TOP2A, XDH | 3.80601 |
| [MF] GO:0019199 | transmembrane receptor protein kinase activity | AXL, FLT3, IGF1R, KDR, KIT, MET | 3.68176 |
| [MF] GO:0019825 | oxygen binding | CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4 | 3.65733 |
| [MF] GO:0004713 | protein tyrosine kinase activity | AXL, DYRK1A, FLT3, IGF1R, KDR, KIT, MET, SRC | 3.62179 |
| [MF] GO:0042562 | hormone binding | ACHE, AR, HSD17B1, IGF1R, NQO2, NR3C1 | 3.53213 |
| [MF] GO:0098531 | transcription factor activity, direct ligand regulated sequence-specific DNA binding | AR, ESR1, PGR, PPARA, RORC | 3.51143 |
| [MF] GO:0004879 | nuclear receptor activity | AR, ESR1, PGR, PPARA, RORC | 3.51143 |
| [MF] GO:0016614 | oxidoreductase activity, acting on CH-OH group of donors | AKR1B1, AKR1B10, HSD11B1, HSD11B2, HSD17B1, HSD17B2, XDH | 3.45753 |
| [MF] GO:0008289 | lipid binding | ALOX15, AR, AXL, CYP3A4, ESR1, F3, FABP4, HSD11B2, HSD17B1, NR3C1, NR3C2, PGR, PPARA, RORC | 3.43683 |
| [MF] GO:0004497 | monooxygenase activity | CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, TYR | 3.29965 |
| [MF] GO:0033764 | steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor | HSD11B1, HSD11B2, HSD17B1, HSD17B2 | 3.22688 |
| [MF] GO:0042802 | identical protein binding | ACHE, APP, BCL2, CSNK2A1, DRD2, DYRK1A, ESR1, FLT3, GRIK5, IGF1R, KDR, KIT, MAOB, MET, MMP9, NQO2, PGR, PTGS2, TERT, TOP2A, TYR, XDH | 3.22197 |
| [MF] GO:0016725 | oxidoreductase activity, acting on CH or CH2 groups | CYP1A2, CYP3A4, XDH | 3.20016 |
| [MF] GO:0016229 | steroid dehydrogenase activity | HSD11B1, HSD11B2, HSD17B1, HSD17B2 | 3.11516 |
| [MF] GO:0009055 | electron transfer activity | AKR1B1, CYP19A1, CYP1A2, MAOB, NQO2, XDH | 3.02924 |
| [MF] GO:0004672 | protein kinase activity | AURKB, AXL, CSNK2A1, DYRK1A, FLT3, IGF1R, KDR, KIT, MET, PIK3CA, PIM1, PRKCA, SRC | 2.97652 |
| [MF] GO:0043560 | insulin receptor substrate binding | IGF1R, PIK3CA, PIK3CB | 2.95071 |
| [MF] GO:0004666 | prostaglandin-endoperoxide synthase activity | PTGS1, PTGS2 | 2.8472 |
| [MF] GO:0003845 | None | HSD11B1, HSD11B2 | 2.8472 |
| [MF] GO:0071886 | None | HTR2A, HTR2C | 2.8472 |
| [MF] GO:0016616 | oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor | AKR1B1, AKR1B10, HSD11B1, HSD11B2, HSD17B1, HSD17B2 | 2.82154 |
| [MF] GO:0016773 | phosphotransferase activity, alcohol group as acceptor | AURKB, AXL, CSNK2A1, DYRK1A, FLT3, IGF1R, KDR, KIT, MET, PIK3CA, PIK3CB, PIM1, PRKCA, SRC | 2.81368 |
| [MF] GO:0016301 | kinase activity | AURKB, AXL, CSNK2A1, DYRK1A, FLT3, IGF1R, KDR, KIT, MET, PIK3CA, PIK3CB, PIM1, PRKCA, SRC | 2.45982 |
| [MF] GO:0050473 | arachidonate 15-lipoxygenase activity | ALOX15, PTGS2 | 2.45399 |
| [MF] GO:0070576 | vitamin D 24-hydroxylase activity | CYP1A1, CYP3A4 | 2.45399 |
| [MF] GO:0004949 | None | CNR1, CNR2 | 2.45399 |
| [MF] GO:0099583 | None | GRM1, GRM5 | 2.45399 |
| [MF] GO:0003674 | molecular_function | ABCB1, ACHE, ADORA3, AKR1B1, AKR1B10, ALOX15, ALOX5, ALPI, ALPL, APEX1, APP, AR, AURKB, AXL, BACE1, BCL2, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CDC25B, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DNMT1, DRD1, DRD2, DYRK1A, ESR1, F3, FABP4, FLT3, FUT7, GLO1, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR4, HTR5A, HTR6, HTR7, IGF1R, KDR, KIT, MAOB, MET, MMP1, MMP12, MMP2, MMP9, NQO2, NR3C1, NR3C2, PDE5A, PGR, PIK3CA, PIK3CB, PIM1, PPARA, PRKCA, PTGS1, PTGS2, PTPN1, RORC, SLC1A1, SRC, TERT, TOP2A, TYR, XDH | 2.37441 |
| [MF] GO:0004970 | None | GRIA2, GRIA4, GRIK5 | 2.31815 |
| [MF] GO:0005234 | None | GRIA2, GRIA4, GRIK5 | 2.31815 |
| [MF] GO:0016772 | transferase activity, transferring phosphorus-containing groups | AURKB, AXL, CSNK2A1, DYRK1A, FLT3, IGF1R, KDR, KIT, MET, PIK3CA, PIK3CB, PIM1, PRKCA, SRC, TERT | 2.29722 |
| [MF] GO:0001223 | transcription coactivator binding | ESR1, PPARA, TERT | 2.25562 |
| [MF] GO:0034875 | caffeine oxidase activity | CYP1A2, CYP3A4 | 2.20616 |
| [MF] GO:0004971 | None | GRIA2, GRIA4 | 2.20616 |
| [MF] GO:0033695 | oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor | CYP1A2, CYP3A4 | 2.20616 |
| [MF] GO:0000166 | nucleotide binding | ABCB1, AURKB, AXL, CSNK2A1, DNMT1, DYRK1A, FLT3, HSD11B2, HSD17B1, IGF1R, KDR, KIT, MAOB, MET, NQO2, PDE5A, PIK3CA, PIK3CB, PIM1, PRKCA, SRC, TOP2A, XDH | 2.1521 |
| [MF] GO:1901265 | nucleoside phosphate binding | ABCB1, AURKB, AXL, CSNK2A1, DNMT1, DYRK1A, FLT3, HSD11B2, HSD17B1, IGF1R, KDR, KIT, MAOB, MET, NQO2, PDE5A, PIK3CA, PIK3CB, PIM1, PRKCA, SRC, TOP2A, XDH | 2.15051 |
| [MF] GO:0101020 | estrogen 16-alpha-hydroxylase activity | CYP1A1, CYP3A4 | 2.0182 |
| [MF] GO:0036094 | small molecule binding | ABCB1, AURKB, AXL, CSNK2A1, DNMT1, DYRK1A, FABP4, FLT3, HSD11B2, HSD17B1, IGF1R, KDR, KIT, MAOB, MET, NQO2, PDE5A, PIK3CA, PIK3CB, PIM1, PRKCA, SLC1A1, SRC, TOP2A, XDH | 2.01617 |
| KEGG Pathway ID | Enriched Genes | Log10 Adjusted P-value |
|---|---|---|
| Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | GRIA2, HTR1E, GRIK5, HTR1D, HTR2B, HTR1A, HTR1B, HTR2C, HTR2A, NR3C1, HTR5A, HTR4, GRM1, GRM3, HTR6, GRM5, HTR7, CNR2, CNR1, ADORA3, GRM8, DRD1, DRD2, GRIA4 | 21.0087 |
| Serotonergic synapse_Homo sapiens_hsa04726 | APP, MAOB, HTR1E, ALOX15, HTR1D, HTR2B, HTR1A, HTR1B, HTR2C, PRKCA, HTR2A, PTGS2, HTR5A, HTR4, PTGS1, HTR6, HTR7, ALOX5 | 20.4072 |
| cAMP signaling pathway_Homo sapiens_hsa04024 | GRIA2, HTR1E, HTR1D, HTR1A, HTR1B, PIK3CB, HTR4, HCAR2, HTR6, PIK3CA, DRD1, DRD2, PPARA, GRIA4 | 10.5261 |
| Ovarian steroidogenesis_Homo sapiens_hsa04913 | ALOX5, HSD17B1, HSD17B2, CYP1A1, CYP1B1, PTGS2, CYP19A1, IGF1R | 8.6306 |
| Steroid hormone biosynthesis_Homo sapiens_hsa00140 | HSD11B1, HSD11B2, HSD17B1, HSD17B2, CYP1A2, CYP1A1, CYP1B1, CYP3A4, CYP19A1 | 9.6321 |
| Calcium signaling pathway_Homo sapiens_hsa04020 | HTR6, GRM5, HTR7, HTR2B, HTR2C, PRKCA, HTR2A, DRD1, HTR5A, HTR4, GRM1 | 7.7387 |
| Gap junction_Homo sapiens_hsa04540 | GRM5, SRC, HTR2B, HTR2C, PRKCA, HTR2A, DRD1, DRD2, GRM1 | 8.0987 |
| Glutamatergic synapse_Homo sapiens_hsa04724 | GRM3, GRIA2, GRM5, GRIK5, GRM8, SLC1A1, PRKCA, GRM1, GRIA4 | 7.1963 |
| Nitrogen metabolism_Homo sapiens_hsa00910 | CA12, CA1, CA2, CA4, CA7, CA9, CA14 | 10.481 |
| Pathways in cancer_Homo sapiens_hsa05200 | FLT3, MMP1, MMP2, PRKCA, PIK3CB, PTGS2, MMP9, IGF1R, AR, PIK3CA, KIT, BCL2, MET | 6.165 |
| Proteoglycans in cancer_Homo sapiens_hsa05205 | PIK3CA, SRC, MMP2, KDR, PRKCA, PIK3CB, MMP9, MET, ESR1, IGF1R | 6.165 |
| Rap1 signaling pathway_Homo sapiens_hsa04015 | PIK3CA, SRC, CNR1, KIT, KDR, PRKCA, PIK3CB, DRD2, MET, IGF1R | 6.075 |
| MicroRNAs in cancer_Homo sapiens_hsa05206 | DNMT1, ABCB1, PIK3CA, BCL2, PIM1, CYP1B1, PRKCA, PTGS2, MMP9, MET, CDC25B | 5.6979 |
| Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | PIK3CA, SRC, HTR2B, HTR2C, PRKCA, PIK3CB, HTR2A | 5.3611 |
| Phospholipase D signaling pathway_Homo sapiens_hsa04072 | GRM3, GRM5, PIK3CA, KIT, GRM8, PRKCA, PIK3CB, GRM1 | 5.3611 |
| AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | PIK3CA, MMP2, BCL2, PIM1, PRKCA, PIK3CB, F3 | 5.35 |
| Estrogen signaling pathway_Homo sapiens_hsa04915 | PIK3CA, SRC, MMP2, PIK3CB, MMP9, ESR1, GRM1 | 5.3611 |
| Metabolic pathways_Homo sapiens_hsa01100 | DNMT1, MAOB, ALOX15, AKR1B1, PTGS2, TYR, CYP3A4, CYP19A1, PTGS1, HSD11B1, FUT7, AKR1B10, ALOX5, HSD17B1, HSD17B2, CYP1A2, CYP1A1, ALPL, ALPI, XDH | 5.0649 |
| VEGF signaling pathway_Homo sapiens_hsa04370 | PIK3CA, SRC, KDR, PRKCA, PIK3CB, PTGS2 | 5.3611 |
| Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | GRIA2, GRM5, CNR1, PRKCA, PTGS2, GRM1, GRIA4 | 5.35 |
| Focal adhesion_Homo sapiens_hsa04510 | PIK3CA, SRC, KDR, BCL2, PRKCA, PIK3CB, MET, IGF1R | 4.439 |
| Ras signaling pathway_Homo sapiens_hsa04014 | HTR7, PIK3CA, KIT, KDR, PRKCA, PIK3CB, MET, IGF1R | 4.1195 |
| Chemical carcinogenesis_Homo sapiens_hsa05204 | HSD11B1, CYP1A2, CYP1A1, CYP1B1, PTGS2, CYP3A4 | 4.7174 |
| Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | FABP4, PIK3CA, PIK3CB, PTGS2, PTGS1 | 4.3413 |
| Acute myeloid leukemia_Homo sapiens_hsa05221 | PIK3CA, FLT3, KIT, PIM1, PIK3CB | 4.32 |
| Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | HSD11B2, PIK3CA, PRKCA, PIK3CB, NR3C2 | 5.06 |
| Amphetamine addiction_Homo sapiens_hsa05031 | GRIA2, MAOB, PRKCA, DRD1, GRIA4 | 4.0206 |
| Dopaminergic synapse_Homo sapiens_hsa04728 | GRIA2, MAOB, PRKCA, DRD1, DRD2, GRIA4 | 3.7464 |
| Cocaine addiction_Homo sapiens_hsa05030 | GRM3, GRIA2, MAOB, DRD1, DRD2 | 4.5955 |
| Central carbon metabolism in cancer_Homo sapiens_hsa05230 | PIK3CA, FLT3, KIT, PIK3CB, MET | 4.0206 |
| Hepatitis B_Homo sapiens_hsa05161 | PIK3CA, SRC, BCL2, PRKCA, PIK3CB, MMP9 | 3.5085 |
| Adherens junction_Homo sapiens_hsa04520 | PTPN1, CSNK2A1, SRC, MET, IGF1R | 3.8386 |
| Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | HSD11B1, CYP1A2, CYP1A1, CYP1B1, CYP3A4 | 3.8533 |
| Prostate cancer_Homo sapiens_hsa05215 | AR, PIK3CA, BCL2, PIK3CB, IGF1R | 3.5166 |
| Taste transduction_Homo sapiens_hsa04742 | HTR1E, HTR1D, HTR1A, HTR1B, GRM1 | 3.6499 |
| PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | PIK3CA, KIT, KDR, BCL2, PRKCA, PIK3CB, MET, IGF1R | 3.074 |
| Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | PIK3CA, PGR, PIK3CB, CDC25B, IGF1R | 3.3407 |
| Cholinergic synapse_Homo sapiens_hsa04725 | ACHE, PIK3CA, BCL2, PRKCA, PIK3CB | 3.1087 |
| HIF-1 signaling pathway_Homo sapiens_hsa04066 | PIK3CA, BCL2, PRKCA, PIK3CB, IGF1R | 3.2497 |
| Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | PIK3CA, SRC, PRKCA, PIK3CB, ESR1 | 3.0447 |
| Leukocyte transendothelial migration_Homo sapiens_hsa04670 | PIK3CA, MMP2, PRKCA, PIK3CB, MMP9 | 3.0447 |
| Sphingolipid signaling pathway_Homo sapiens_hsa04071 | PIK3CA, ADORA3, BCL2, PRKCA, PIK3CB | 3.0293 |
| Oxytocin signaling pathway_Homo sapiens_hsa04921 | PIK3CA, SRC, PRKCA, PIK3CB, PTGS2 | 2.5507 |
| Long-term depression_Homo sapiens_hsa04730 | GRIA2, PRKCA, GRM1, IGF1R | 3.1087 |
| Glioma_Homo sapiens_hsa05214 | PIK3CA, PRKCA, PIK3CB, IGF1R | 3.0332 |
| TNF signaling pathway_Homo sapiens_hsa04668 | PIK3CA, PIK3CB, PTGS2, MMP9 | 2.2636 |
| Insulin resistance_Homo sapiens_hsa04931 | PTPN1, PIK3CA, PIK3CB, PPARA | 2.2706 |
| Bladder cancer_Homo sapiens_hsa05219 | SRC, MMP1, MMP2, MMP9 | 3.6803 |
| ErbB signaling pathway_Homo sapiens_hsa04012 | PIK3CA, SRC, PRKCA, PIK3CB | 2.6187 |
| Melanoma_Homo sapiens_hsa05218 | PIK3CA, PIK3CB, MET, IGF1R | 2.9212 |
| Prolactin signaling pathway_Homo sapiens_hsa04917 | PIK3CA, SRC, PIK3CB, ESR1 | 2.9062 |
| Arachidonic acid metabolism_Homo sapiens_hsa00590 | ALOX5, ALOX15, PTGS2, PTGS1 | 3.074 |
| Platelet activation_Homo sapiens_hsa04611 | PIK3CA, SRC, PIK3CB, PTGS1 | 2.1288 |
| Small cell lung cancer_Homo sapiens_hsa05222 | PIK3CA, BCL2, PIK3CB, PTGS2 | 2.6297 |
| Toxoplasmosis_Homo sapiens_hsa05145 | PIK3CA, ALOX5, BCL2, PIK3CB | 2.1742 |
| Long-term potentiation_Homo sapiens_hsa04720 | GRIA2, GRM5, PRKCA, GRM1 | 3.0257 |
| Tryptophan metabolism_Homo sapiens_hsa00380 | MAOB, CYP1A2, CYP1A1, CYP1B1 | 3.7104 |
| Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | PIK3CA, SRC, PIK3CB, MET | 2.782 |
| FoxO signaling pathway_Homo sapiens_hsa04068 | PIK3CA, PIK3CB, GRM1, IGF1R | 2.0278 |
| Endocytosis_Homo sapiens_hsa04144 | SRC, KIT, KDR, MET, IGF1R | 1.7597 |
| Jak-STAT signaling pathway_Homo sapiens_hsa04630 | PIK3CA, BCL2, PIM1, PIK3CB | 1.8128 |
| Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | PIK3CA, BCL2, PRKCA, PIK3CB | 1.9062 |
| cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | PIK3CA, ADORA3, PDE5A, PIK3CB | 1.7409 |
| Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | FLT3, MMP9, MET, IGF1R | 1.6724 |
| Huntington's disease_Homo sapiens_hsa05016 | GRM5 | 0.2226 |
| Herpes simplex infection_Homo sapiens_hsa05168 | CSNK2A1 | 0.2316 |
| Epstein-Barr virus infection_Homo sapiens_hsa05169 | CSNK2A1, PIK3CA, BCL2, PIK3CB | 1.5433 |
| Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | BCL2 | 0.2543 |
| GnRH signaling pathway_Homo sapiens_hsa04912 | SRC, MMP2, PRKCA | 1.6972 |
| Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | PIK3CA, PRKCA, PIK3CB | 1.6824 |
| Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | PIK3CA, PRKCA, PIK3CB | 1.9893 |
| Axon guidance_Homo sapiens_hsa04360 | MET | 0.338 |
| Cell cycle_Homo sapiens_hsa04110 | CDC25B | 0.3431 |
| Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | PIK3CA, PIK3CB, IGF1R | 1.6803 |
| Circadian entrainment_Homo sapiens_hsa04713 | GRIA2, PRKCA, GRIA4 | 1.6731 |
| mTOR signaling pathway_Homo sapiens_hsa04150 | PIK3CA, PRKCA, PIK3CB | 2.1038 |
| Vascular smooth muscle contraction_Homo sapiens_hsa04270 | PRKCA | 0.3512 |
| Melanogenesis_Homo sapiens_hsa04916 | KIT, PRKCA, TYR | 1.636 |
| MAPK signaling pathway_Homo sapiens_hsa04010 | PRKCA, CDC25B | 0.4409 |
| Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | PIK3CA, PIK3CB, IGF1R | 2.0378 |
| NF-kappa B signaling pathway_Homo sapiens_hsa04064 | CSNK2A1, BCL2, PTGS2 | 1.6824 |
| Neurotrophin signaling pathway_Homo sapiens_hsa04722 | PIK3CA, BCL2, PIK3CB | 1.4556 |
| Amoebiasis_Homo sapiens_hsa05146 | PIK3CA, PRKCA, PIK3CB | 1.636 |
| Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | PIK3CA, PRKCA, PIK3CB | 1.6467 |
| Non-small cell lung cancer_Homo sapiens_hsa05223 | PIK3CA, PRKCA, PIK3CB | 2.1742 |
| Choline metabolism in cancer_Homo sapiens_hsa05231 | PIK3CA, PRKCA, PIK3CB | 1.6312 |
| Oocyte meiosis_Homo sapiens_hsa04114 | AR, PGR, IGF1R | 1.4365 |
| Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | FLT3, KIT, KDR, MET | 1.2452 |
| Renal cell carcinoma_Homo sapiens_hsa05211 | PIK3CA, PIK3CB, MET | 2.0196 |
| Glucagon signaling pathway_Homo sapiens_hsa04922 | PPARA | 0.4058 |
| Purine metabolism_Homo sapiens_hsa00230 | PDE5A, XDH | 0.6249 |
| Colorectal cancer_Homo sapiens_hsa05210 | PIK3CA, BCL2, PIK3CB | 2.0702 |
| AMPK signaling pathway_Homo sapiens_hsa04152 | PIK3CA, PIK3CB, IGF1R | 1.4362 |
| Measles_Homo sapiens_hsa05162 | CSNK2A1, PIK3CA, PIK3CB | 1.3578 |
| Hepatitis C_Homo sapiens_hsa05160 | PIK3CA, PIK3CB, PPARA | 1.3738 |
| Apoptosis_Homo sapiens_hsa04210 | PIK3CA, BCL2, PIK3CB | 1.3378 |
| Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | PIK3CA, PRKCA, PIK3CB | 1.3619 |
| Tuberculosis_Homo sapiens_hsa05152 | SRC, BCL2 | 0.6205 |
| Insulin signaling pathway_Homo sapiens_hsa04910 | PTPN1, PIK3CA, PIK3CB | 1.3417 |
| Glycerophospholipid metabolism_Homo sapiens_hsa00564 | ACHE | 0.4242 |
| Alzheimer's disease_Homo sapiens_hsa05010 | BACE1, APP | 0.6486 |
| HTLV-I infection_Homo sapiens_hsa05166 | PIK3CA, TERT, PIK3CB | 0.8019 |
| Tight junction_Homo sapiens_hsa04530 | CSNK2A1, SRC, PRKCA | 1.3417 |
| Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | PIK3CA, PIK3CB, PPARA | 1.2663 |
| Parkinson's disease_Homo sapiens_hsa05012 | DRD1, DRD2 | 0.7476 |
| Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | PIK3CA, PIK3CB, IGF1R | 1.3261 |
| Retinol metabolism_Homo sapiens_hsa00830 | CYP1A2, CYP1A1, CYP3A4 | 2.0278 |
| Viral carcinogenesis_Homo sapiens_hsa05203 | PIK3CA, SRC, PIK3CB | 0.9944 |
| Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | PIK3CA, SRC, PIK3CB | 0.9614 |
| Rheumatoid arthritis_Homo sapiens_hsa05323 | MMP1 | 0.4403 |
| Alcoholism_Homo sapiens_hsa05034 | MAOB, DRD1, DRD2 | 1.1174 |
| Wnt signaling pathway_Homo sapiens_hsa04310 | CSNK2A1, PRKCA | 0.7476 |
| Salivary secretion_Homo sapiens_hsa04970 | PRKCA | 0.4403 |
| Influenza A_Homo sapiens_hsa05164 | PIK3CA, PRKCA, PIK3CB | 1.1376 |
| Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | MAOB, CYP1A2, CYP3A4 | 1.9838 |
| Osteoclast differentiation_Homo sapiens_hsa04380 | PIK3CA, PIK3CB | 0.7836 |
| Bile secretion_Homo sapiens_hsa04976 | ABCB1, CA2, CYP3A4 | 1.9551 |
| Chemokine signaling pathway_Homo sapiens_hsa04062 | PIK3CA, SRC, PIK3CB | 1.0752 |
| Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | CSNK2A1 | 0.4403 |
| Protein digestion and absorption_Homo sapiens_hsa04974 | SLC1A1 | 0.4403 |
| Insulin secretion_Homo sapiens_hsa04911 | PRKCA | 0.4472 |
| Peroxisome_Homo sapiens_hsa04146 | XDH | 0.453 |
| PPAR signaling pathway_Homo sapiens_hsa03320 | FABP4, MMP1, PPARA | 1.9838 |
| Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | PRKCA | 0.459 |
| Complement and coagulation cascades_Homo sapiens_hsa04610 | F3 | 0.4652 |
| Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | PIK3CA, PIK3CB | 0.9255 |
| Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | PIK3CA, PIK3CB | 0.9363 |
| Leishmaniasis_Homo sapiens_hsa05140 | PTGS2 | 0.4911 |
| T cell receptor signaling pathway_Homo sapiens_hsa04660 | PIK3CA, PIK3CB | 0.9363 |
| Adipocytokine signaling pathway_Homo sapiens_hsa04920 | PPARA | 0.5009 |
| Pancreatic secretion_Homo sapiens_hsa04972 | CA2, PRKCA | 0.9821 |
| Thyroid hormone synthesis_Homo sapiens_hsa04918 | PRKCA | 0.4984 |
| Morphine addiction_Homo sapiens_hsa05032 | PRKCA, DRD1 | 1.0154 |
| Hematopoietic cell lineage_Homo sapiens_hsa04640 | FLT3, KIT | 1.0373 |
| GABAergic synapse_Homo sapiens_hsa04727 | SRC, PRKCA | 1.0373 |
| Shigellosis_Homo sapiens_hsa05131 | SRC | 0.5255 |
| Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | RORC | 0.5255 |
| Chronic myeloid leukemia_Homo sapiens_hsa05220 | PIK3CA, PIK3CB | 1.1595 |
| B cell receptor signaling pathway_Homo sapiens_hsa04662 | PIK3CA, PIK3CB | 1.1595 |
| Gastric acid secretion_Homo sapiens_hsa04971 | CA2, PRKCA | 1.1526 |
| Inositol phosphate metabolism_Homo sapiens_hsa00562 | PIK3CA, PIK3CB | 1.1737 |
| Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | PRKCA | 0.5827 |
| Pancreatic cancer_Homo sapiens_hsa05212 | PIK3CA, PIK3CB | 1.2234 |
| Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | SRC, MET | 1.2038 |
| Vibrio cholerae infection_Homo sapiens_hsa05110 | PRKCA | 0.6087 |
| Arginine and proline metabolism_Homo sapiens_hsa00330 | MAOB | 0.6135 |
| Malaria_Homo sapiens_hsa05144 | MET | 0.6185 |
| Endometrial cancer_Homo sapiens_hsa05213 | PIK3CA, PIK3CB | 1.3738 |
| Glycerolipid metabolism_Homo sapiens_hsa00561 | AKR1B10, AKR1B1 | 1.3009 |
| ABC transporters_Homo sapiens_hsa02010 | ABCB1 | 0.6486 |
| Cysteine and methionine metabolism_Homo sapiens_hsa00270 | DNMT1 | 0.6428 |
| Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | GRIA2, BCL2 | 1.381 |
| Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | PIK3CA, PIK3CB | 1.4556 |
| Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | PRKCA, ESR1 | 1.4362 |
| Type II diabetes mellitus_Homo sapiens_hsa04930 | PIK3CA, PIK3CB | 1.426 |
| Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | MAOB | 0.6801 |
| Drug metabolism - other enzymes_Homo sapiens_hsa00983 | CYP3A4, XDH | 1.443 |
| Pyruvate metabolism_Homo sapiens_hsa00620 | GLO1 | 0.6801 |
| Linoleic acid metabolism_Homo sapiens_hsa00591 | ALOX15, CYP1A2, CYP3A4 | 2.9292 |
| African trypanosomiasis_Homo sapiens_hsa05143 | PRKCA | 0.727 |
| Nicotine addiction_Homo sapiens_hsa05033 | GRIA2, GRIA4 | 1.5433 |
| Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | FUT7 | 0.7635 |
| Galactose metabolism_Homo sapiens_hsa00052 | AKR1B10, AKR1B1 | 1.7082 |
| Base excision repair_Homo sapiens_hsa03410 | APEX1 | 0.7476 |
| Fructose and mannose metabolism_Homo sapiens_hsa00051 | AKR1B10, AKR1B1 | 1.6803 |
| Tyrosine metabolism_Homo sapiens_hsa00350 | MAOB, TYR | 1.636 |
| Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | FUT7 | 0.8187 |
| Circadian rhythm_Homo sapiens_hsa04710 | RORC | 0.7734 |
| Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | AKR1B10, AKR1B1 | 1.6221 |
| Collecting duct acid secretion_Homo sapiens_hsa04966 | CA2 | 0.8066 |
| Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | CA2, CA4 | 1.9062 |
| Histidine metabolism_Homo sapiens_hsa00340 | MAOB | 0.8483 |
| Phenylalanine metabolism_Homo sapiens_hsa00360 | MAOB | 0.9743 |
| Folate biosynthesis_Homo sapiens_hsa00790 | ALPL, ALPI | 2.2452 |
| Caffeine metabolism_Homo sapiens_hsa00232 | CYP1A2, XDH | 3.0648 |